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Abstract 
A system is needed to prevent pressure ulcers and to relieve some workload that medical 
professionals must take on in order to care for patients susceptible to pressure ulcer formation. 
Currently, an electronic pressure sensor is being developed that would alert a healthcare 
professional that their patient is at risk of forming a pressure ulcer. Medical material studies were 
conducted to determine which material would best adhere this wearable sensor to the body for a 
maximum of seven days and not cause skin irritation, while protecting the electronic 
components. The final patch was comprised of Tegaderm™ Film Dressing by 3M Co. in an “I” 
shape. This design was able to remain adhered to the body for upwards of seven days, did not 
cause more than mild skin irritation, and was able to resist water penetration. Future work should 
further test different shapes using the sensor on different parts of the body while obtaining larger 
sample sizes for more robust conclusions. 
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Executive Summary 
Pressure ulcers are localized tissue injures that are common in hospital settings and paralyzed 
individuals. Often they develop due to increased and prolonged pressure at bony prominences 
restricting blood flow and causing tissue death, but shear and frictional forces contribute to the 
degradation of the tissues as well. Over 1 million people develop these sores yearly and 60,000 
people die due to pressure ulcer related complications, so there is a significant need to prevent 
them [1]. 
 The current gold standard for preventing pressure ulcers is to have nurses turn patients 
every two hours, but this is time consuming and so can often not be performed effectively [2]. 
Additional strategies to prevent pressure ulcers include offloading that uses cushions to disperse 
pressure from bony prominences, pressure mapping to monitor pressures over the entire, and 
wearable sensors that track the motion of the patient to ensure the patient is being turned [3-5]. 
While all these methods have their merits, there is still not an affordable system that 
systematically measures various local conditions and uses that information to alert a medical 
professional about an impending pressure ulcer. 
 Currently a WPI PhD student and a separate MQP team is working on a sensor to help 
prevent pressure ulcers by measuring pressure, temperature, and moisture [6]. Our team was 
tasked with developing the adhesive packaging that would house this disposable sensor and 
adhere it to at risk areas of the body. Additionally, this patch needed be comfortably worn for 
seven days, water resistant, and biocompatible while costing less than twenty dollars. 
 To address this design problem, the MQP was divided into two major parts: the material 
selection process and the development of the patch shape. ASTM standards for assessing elastic 
modulus, water resistance, and adhesive shear, peel, and loop tack strengths were adapted to 
form the protocols that the team followed to analyze the mechanical properties of fourteen 
adhesive medical products [7-11]. This would determine the material to use for the patch. Elastic 
modulus determined if the material would bend with the body without pulling and damaging the 
skin.  Water resistance was important for ensuring the electrical components will not be damaged 
or short on the person when they bathe, sweat, or soil themselves. Adhesive shear strength 
determined if the material would be able to remain attached to the skin throughout normal wear 
of the patch. Adhesive peel strength ensured that the patch would not damage skin upon removal. 
Adhesive loop tack determined if a recently, but incorrectly, placed patch would be able to be 
removed and readjusted easily and without damaging the skin. 
 The data from these tests were entered into a design matrix using differing weighting 
factors for each test based on the importance of the test on the performance of the patch material. 
Using the top two performing materials from this process, a duration study was performed on the 
team members according to an FDA guidance document for assessing transdermal patches in 
order to determine which material adhered the longest in practice. From this test, it was 
determined that TransporeTM by 3M Co. adhered significantly better throughout the course of the 
study. 
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 Later in the MQP, a WPI IRB approved user questionnaire was performed to determine 
which preliminary patch shape designs would be most intuitive to people in order for the sensor 
component to record accurate measurements. Using this information and additional user 
feedback, the team created two updated patch designs an “I” shape and a “cross” shape. With 
these shapes, another duration study was performed like before, but using the full patch shape 
and TransporeTM on the team members’ heals and elbows. This verified which shape was best 
and validated that the patch remained adhered for the seven days. Due to notable skin irritation, 
the material for this study was replaced with the next best material, TegadermTM by 3M Co., and 
the results of the test yielded that the “I” shape performed best out of the two designs.  
 As two final validation studies, the full “I” shaped patch using TegadermTM material was 
tested for water resistance the same way as the previous material water resistance test. This test 
proved that the patch could withstand being in contact with water for five hours. Finally, the 
team coordinated with the electronics MQP team to perform testing of the flex circuit board 
component integrated inside the patch. When this was done, the electronics team confirmed that 
the sensor was still reading pressure, temperature, and moisture measurements. When this 
integrated patch was put on a team member’s elbow, she noted that it was comfortable and able 
to stretch and bend with the arm, and she could not feel the electronic components because of the 
polyethylene foam padding layers.  
 The final patch was comprised of TegadermTM Film Dressing by 3M Co. in an “I” shape. 
The team recommends future designs using rounded corners to reduce stress concentrations at 
these points that could cause the patch to tear or detach from the body causing it to fail. Further 
testing should be conducted using different shapes on different parts of the body and obtaining a 
larger sample size for more robust conclusions. Additional tests should include the electronic 
components integrated in the patch to determine if they remain functional and accurate for the 
full seven days. 
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1. CHAPTER 1: Introduction 
Pressure ulcers are localized injuries that form due to bony prominences causing localized tissue 
ischemia. This lack of blood circulation results in necrosis of these underlying tissues and open 
sores that can become infected, and in some severe cases, cause death. Approximately 1 million 
people in the United States alone are affected by pressure ulcers each year, and of this 
population, nearly 60,000 people die as a direct result of pressure ulcers [1]. This ends up adding 
up to 3.7 billion USD each year in just lawsuits and litigation and 11 billion USD for treatment 
[1]. Therefore, there is a significant need to find a prevention system to avoid the consequences 
that come with pressure ulcers. 
Currently, there are a few methods to prevent pressure ulcers from occurring. The 
standard method in hospitals is patient turning. This involves a healthcare professional, such as a 
nurse, physically turning the patient every two hours to relieve pressure in certain risk areas that 
are known to cause pressure ulcers [2]. Although this is an effective method, it can be quite time 
consuming for healthcare professionals, and for this reason, it often fails since they are unable to 
do it efficiently [2]. Another common method is offloading, which involves padding certain risk 
areas to relieve excessive pressure. This can take the form of adding extra pillows under a patient 
or using specialized beds. However, this can often be expensive and only applies to certain areas 
of the body [5]. Recently, pressure mapping beds have been developed. This system monitors the 
patient in their hospital bed and can indicate that a pressure ulcer may form when pressures 
exceed a certain threshold. Unfortunately, the bed’s coordinate map is according to the bed and 
not the patient [3]. This method would not be able to detect that the patient may be moving in 
their bed while still applying pressure to the same part of their body. Not only is there a need to 
find a prevention system, but there is a need to find a more effective and affordable prevention 
system. 
A graduate student at Worcester Polytechnic Institute (WPI), Devdip Sen, is currently 
developing a sensor (Figure 1.1A) that would be able to detect pressure ulcer formation before it 
actually occurred [6]. The finished product will be a flexible printed circuit board that will be 
able to measure pressure, temperature, and moisture and alert a healthcare professional that their 
patient is at risk of forming a pressure ulcer. Although this is a useful, novel sensor, it will not be 
able to collect data if it is not properly adhered to the body. This was the problem the team 
sought to solve. The team was posed with the task to find a material that would be water 
resistant, biocompatible, and comfortable to the user that would remain adhered to the body for a 
maximum of seven days. In addition, the team was also posed with designing the shape of the 
patch that would hold the flexible printed circuit board (flex PCB) with the sensor. The patch 
design (Figure 1.1B) needed to be such that it would meet the goals of the project when placed 
on heels and elbows which are two major locations where pressure ulcers form. After conducting 
various verification and validation tests, the team was able to identify the most appropriate patch 
material and shape to meet the needs of the project. 
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Figure 1.1: Flex PCB Developed by Electronics Team (A); PCB Encased in Adhesive Patch (B) 
The team tested several adhesive medical products with different backing and adhesive 
material combinations. These tapes were put through a series of five different material tests 
which were adapted from different standards published by the American Society for Testing and 
Materials (ASTM). These tests were chosen based on the client statement with which the team 
was presented. 
The first test the team conducted was an elastic modulus test. The material chosen for the 
final application should be as compliant as human skin, so the user’s skin would not be irritated 
by this material. The second test focused on the shear strength of the material. Shear forces are 
often applied on a patient when they shift in a hospital bed, so the medical adhesive should be 
able to withstand these shear forces to stay in place on the patient. The third test was a peel force 
test that ensure that the material would not damage the skin when removed. Next, the team 
looked into water resistance. This was a particularly important property for this application 
because patients will be bathed or may soil themselves; therefore, water resistance is important 
to protect the electronics and the patient. Lastly, the team looked into loop tack force to ensure 
Pressure Sensor 
Moisture and  
Temperature Sensor 
Microcontroller 
Adhesive Material 
Circuit Board 
A 
B 
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the medical adhesive material was not cumbersome to use or damaging to the skin if it was 
placed incorrectly and needed to be repositioned. 
The raw results were normalized and multiplied by the weighting factor that 
corresponded to the specific material test. From background research, the team assigned the 
weighting factors to the material tests in an order that the team believed were most important to 
consider when choosing the material. To ensure the weights were appropriate, these weighting 
factors were confirmed with the plastic surgeons also involved with the project who work with 
pressure ulcers daily at University of Massachusetts Memorial Medical Center.  
The team conducted a duration test of the top two materials from these five tests for two 
reasons: 1) to decide which material was the best for our application and 2) to see if there was 
any difference in adhesion when using an AllKare® Protective Barrier Wipe by ConvaTec Inc.. 
Small samples were adhered to the team member’s skin, some with the barrier wipe and some 
without, and observed for ten days. This duration test revealed that the material that stayed on the 
longest was Transpore™ surgical tape by 3M Co. and the use of the AllKare® Protective Barrier 
Wipe made no significant difference. 
To further ensure this was the best possible material for the patch, the team wore patches 
made of Transpore™ tape with mock flex PCBs and observed how the patches adhered on their 
elbows and heels. After three days of observation, the team members concluded this material was 
a failure with respect to biocompatibility and comfort. The team members experienced itching, 
skin tearing, and skin deterioration while wearing the Transpore™ patch, which lead us to 
conduct the test once more with the second material, Tegaderm™ Film Dressing by 3M Co. This 
material was able to stay on the body for an average of 5 days while also remaining comfortable. 
The team concluded that Tegaderm™ Film Dressing by 3M Co. was the best material to use for 
this application. 
In addition to material tests, the team looked into the shape and design of the patch itself. 
After a process of brainstorming and redesigning, the team created three major designs: a 
rectangle shape, an “I” shape, and a “cross” shape. The team wanted to gauge how intuitive the 
patch shape would be, because if the shape was not intuitive, the sensor would not be applied 
correctly and therefore become ineffective. Feedback from a questionnaire led the team to 
conclude that the “I” shaped patch was the most intuitive with the “cross” shaped patch coming 
in second. 
Based on this data, the team tested patch shapes on themselves, comparing the “cross” 
shape and the “I” shape against one another. Results showed the “I” shape stayed adhered to the 
body longest and was the most comfortable to wear. The team concluded that the “I” shape 
would be the best for a sensor that would be applied to the elbow and heel. Overall, the team was 
able to design a patch that would encase the sensor being developed and met all the needs and 
most of the wants of the project. 
The following chapters 2 through 8 will detail the process and rational this MQP team 
followed to complete this project. Chapter 2 lays out a detailed literature review on pressure 
ulcers themselves, the pressure ulcer industry, current methods of prevention, and medical 
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adhesives and patches. Chapter 3 outlines the initial client statement, the final client statement, 
the constraints and objectives of this project, and the regulations and standards followed in that 
process. Chapter 4 goes through all the preliminary testing and methods conducted. Chapter 5 
and Chapter 6 address our design verification and validation respectively followed by Chapter 7 
which discusses and dissects the results from the two previous chapters. Finally, in Chapter 8 
there are concluding statements that sum up the entirety of the project. 
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2. CHAPTER 2: Literature Review 
2.1 Background on Ulcer Formation 
 Definition 
 Pressure ulcers, or bedsores, are an unfortunate complication many bedridden patients 
and those in wheelchairs encounter. Pressure ulcers are localized injuries due to pressure and/or 
shear and friction against a person’s skin. These forces against the body cause damage to 
underlying tissues [12]. Typically, the initial layers of the skin and underlying fat are damaged, 
but in severe cases, muscle and bone can be damaged as well. 
 Explanation of Formation 
 Pressure ulcers are predominantly formed due to excessive pressure. This constant 
pressure occurs from bone pushing against the layers of the skin and a hard surface also putting 
force on the other side of the body, causing a restriction of blood flow from both directions. This 
restriction prevents oxygen and other nutrients from reaching underlying tissues which can cause 
damage to the tissue, and in some cases, even necrosis.  
Pressure ulcers can be complicated by shear forces against the body as well. Unlike 
pressure forces which act perpendicular to the skin, shear forces occur in parallel with the skin 
[13]. Shear forces cause skin layers to shift over one another which can cause further damage to 
the skin. Shear forces are not always a factor in ulcer formation, but they are a common cause. 
In addition, friction forces can further complicate pressure ulcer formation. Friction is 
similar to shear, in the sense that these forces are in parallel with the skin. However, friction is 
when one surface is in motion, while another surface is stationary and the two rub against each 
other [14]. With shear, both surfaces are in motion, being moved in opposing directions. Both 
friction forces and shear forces can cause the skin to tear and further complicate the ulcer. 
 Risk Factors 
 A number of factors can affect the chances of ulcer formation, typically affecting the 
overall health and functionality of the skin. These factors include, but are not limited to: age, 
immobility, poor nutrition, bowel incontinence, moisture level, poor blood flow, and smoking. 
Age affects the structure of the skin. As humans age the skin is not as likely to repair and 
regenerate as often as it once could. This causes the skin to become thinner because new skins 
cells are not forming as frequently. In general, as cells age, they are not as likely to produce or 
secrete various molecules as often as they originally could. The skin will not produce as much 
collagen, which is responsible for giving the skin its elasticity and strength. With skin being 
thinner and not as strong, an ulcer is more likely to form due to the lack of layers between a bony 
prominence and the outer layers of the skin [15]. 
Immobility can increase the risk of an individual developing an ulcer. If the patient is 
unable to move their body consciously, they will not be able to adequately alleviate the pressure 
on certain areas of the body. If this cannot occur, the chances of forming an ulcer are higher. 
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Nutrition is also a factor in ulcer formation. Without proper nutrition, skin will not be 
optimally healthy. This may cause the skin to thin and weaken, thus reducing its integrity and 
ability to withstand pressures from bony prominences. 
Excessive moisture or dryness can increase the chances of forming an ulcer. In either 
condition, the skin is more likely to shear or cause friction, which can break the skin already 
under pressure[16]. 
Bowel incontinence can also contribute to excessive moisture in certain areas. This 
increases the negative effects of shear and friction forces against the skin, further increasing the 
chances of the skin breaking. 
Lack of blood flow in the body can contribute to pressure ulcer formation. As the lack of 
blood flow decreases it starves body tissues of nutrients. This can damage and weaken the skin 
and the layers below the skin, making these tissues more susceptible to ulcer formation. 
Smoking has a few effects that can increase the risk of ulcer formation [14]. Smoking can 
make the skin less elastic and weaker, cause poor blood flow, and decrease oxygen in the blood. 
This leaves the tissue more likely to deform under pressure and shear forces because it is weaker 
and not healthy. 
 Common Sites on the Body 
High risk areas are those that are near or on areas where there is a bony prominence that would 
subject skin capillaries to high pressure forces when the patient is lying down or sitting up. Such 
high risk areas are highlighted in Figure 2.1. 
 
Figure 2.1: The Common Sites for Pressure Ulcer Formation. 
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 Groups at Higher Risk 
Typically, those who are in hospital beds, wheelchairs, or nursing homes are more likely 
to form ulcers because these individuals are usually in a lying down or sitting position which 
causes excessive pressure against capillaries. It is not guaranteed that if a person is subjected to 
one of the following situations that an ulcer will form, but it does increase the risk. Of these 
people, typically the following groups are more likely to develop ulcers: the elderly, those who 
recently lost weight, and those with a lack of mobility. 
Elderly people are more likely to develop pressure ulcers [16]. As the skin ages, it 
becomes weaker. Cells are not as likely to proliferate and create collagen, a major molecule 
found in the skin that gives the skin strength. With this loss of cells and strength, the tissue is 
more likely to be damaged with added pressure forces. In addition, due to the lack of 
proliferation and creation of collagen, if a pressure ulcer is formed it will not heal as quickly and 
persist longer than usual. This could cause the ulcer to increase in depth and surface area, making 
it harder and more expensive to treat. 
Those who have recently lost weight are also more likely to develop pressure ulcers. The 
weight loss results in a decrease in adipose tissue, which can certainly be beneficial for the 
person. However, adipose tissue protects the body by cushioning it and absorbing forces placed 
on the body. Without adipose tissue, there is not a layer of protection between the bone and the 
skin. Therefore, this lack of adipose tissue increases the risk of developing a pressure ulcer. 
Those who are immobile or lack sensation have also been found to be more likely to form 
pressure ulcers. For those patients that cannot move on their own easily, relieving the pressure on 
the body can be fairly difficult. If the pressure is not relieved in time, an ulcer may form. For 
those with a lack of sensation, they are also not able to relieve the pressure in time but instead 
because they simply do not feel the pain. Although not due to immobility, this is still a group of 
people who suffer in a similar manner. This group of people may include those who are 
paralyzed, who are disabled, and who suffer from an immobilizing disease. 
2.2 Diagnosis and Treatment 
 Various Stages of Ulcer Progression 
Ulcers fall into different categories depending on the severity of the wound. By 
diagnosing which stage they fall under, health professionals can provide the appropriate 
treatment recommended for the specific stage. Figure 2.2 depicts the various stages of pressure 
ulcer formation. 
Stage 1 ulcers appear similar to a blister, but the skin does not bubble as much. There is 
red discoloration and when touched, it will not blanch. The area is sensitive and may be 
significantly warmer or cooler than the surrounding skin. 
Stage 2 appears much more like a blister with the skin either bubbles a bit or may even be 
broken. If the skin is broken, there may even be a shallow wound. The injury is not very deep, 
but it is common for the epidermis and dermis to be damaged. 
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Stage 3 ulcers are a deep wound that look almost like a crater. Skin continues to peel 
away and adipose tissue can be exposed. The bottom of the wound may have dead tissue. 
Stage 4 is an even deeper injury, possibly exposing tissues found underneath the skin 
layers. This includes muscle, bones, and tendons. It is not uncommon that the bottom of the 
wound is permanently damaged tissue. 
 
Figure 2.2: Medical Illustration of Pressure Ulcer Stages 
 Protocols for Treatment 
Treatment depends on the severity of the ulcer. For Stage 1 and 2, cleaning and dressing 
the wound, repositioning to alleviate pressure, and choosing softer, more supportive surfaces are 
three effective methods. For Stage 3 and 4, due to the extensive tissue damage, those three 
methods are not enough. It may be necessary to remove the damaged tissue through surgery and 
if infected, treat it with antibiotics. In some cases, ulcers can become cancerous, in which case 
treatment would include chemotherapy [16]. 
Because of the risk factors and complications, pressure ulcers can be extremely hard to 
treat. These open wounds can cause a great amount of permanent damage that even surgery may 
not fully repair. In some cases, the blood vessels stop functioning properly which prohibits the 
damaged tissue from getting nutrients it needs to repair itself. This results in a long recovery 
time. The current prevention protocols also contribute to the length of recovery. For example, if a 
patient forms an ulcer on their right hip, the nurse may reposition the patient to lay on their back 
to alleviate the pressure from their hip. However, this new position may cause a pressure ulcer to 
form on another high risk area, increasing recovery time.  
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2.3 Ulcer Industry and Government 
 Cost of Pressure Ulcers 
Pressure ulcers affect roughly 1 million people in the United States each year and 60,000 
people die as a direct result of pressure ulcers annually [17]. Pressure ulcers are a preventable 
condition and yet 3.5% to 4.5% of all hospitalized patients in the US develop them [17]. This is a 
serious medical issue affecting a large number of people and has the potential to be completely 
avoided. Besides the burden to the patients that develop these, pressure ulcers also create a 
financial burden to the medical industry as a whole.  
Pressure ulcer related costs are the third highest medical cost behind only cardiovascular 
disease and cancer [1]. In the US alone, it is estimated that treating pressure ulcers costs 11 
billion dollars annually [17]. For one stage 1 ulcer, it can cost anywhere from 2,000 USD to 
10,700 USD and for one stage 2 ulcer, the cost to treat it ranges from 3,000 to roughly 10,700 
USD. Stage 3 and 4 pressure ulcers are even more expensive to treat ranging from 5,900 USD to 
14,840 USD and 18,730 USD to 21,410 USD respectively for a single ulcer [17]. To put it in 
perspective, for just one hospital, Leaf healthcare estimated that l with roughly 15,000 
admissions per year and an ulcer development rate of 3.5%, the hospital would save roughly 1.6 
million dollars annually if the ulcer development rate dropped by just 1% [17].  
 Government and Litigation 
There are also government and litigation factors to take into account when trying to 
understand the need for pressure ulcer reduction. As of 2008, it was decided that 
Medicare/Medicaid does not reimburse hospitals for costs related to pressure ulcers that are 
developed while under hospital care in the US [18]. This essentially means that Medicare does 
not cover the costs to treat the pressure ulcers if they developed while the patient was 
hospitalized because they are classified as a preventable condition. As of 2014, as a part of the 
Affordable Care Act, it was decided that hospitals that fall into the top 25% of hospitals with the 
highest rates of hospital acquired pressure ulcers would receive a 1% reduction of payment for 
all their Medicare patients [17]. In essence, the United States government is putting the pressure 
on the healthcare industry to find a solution in pressure ulcer prevention through financial 
penalties. Pressure to find a solution does not come only from the government but from the 
patients as well. 
Pressure ulcer related lawsuits are the second leading reason for lawsuits, with over 
17,000 filed annually. It is second only to wrongful death lawsuits. The average settlement for a 
pressure ulcer lawsuit is $250,000 USD and one study found that pressure ulcer lawsuits favor 
patients roughly 87% of the time [17]. With an average settlement of $250,000 USD and 14,790 
lawsuits (87% of 17,000) going in the favor of the patients, this represents a financial burden of 
3.7 billion USD annually in litigation alone [17]. This is just another significant financial burden 
on the medical industry. The medical industry would greatly benefit from a device that would 
lower the rate of hospital acquired pressure ulcers. 
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2.4 Current Methods of Prevention 
There are a few current methods of pressure ulcer prevention currently in use or on the 
market. These methods include physically turning patients, offloading, pressure mapping, and 
motion sensing and they each have certain advantages and limitations.  
 Turning 
Turning is the current standard procedure done for patients to prevent ulcer formation. 
This involves physically repositioning or turning a patient every 2-3 hours. When done on a 
timely schedule this can help to reduce pressure ulcer development but it puts a strain on 
caretakers and nurses to have to do this so frequently. This method also only works for patients 
that rely on caregivers, and can be disruptive to patients’ sleep schedules [2].  
 Offloading 
Offloading involves either specialized padding or pillows targeted at specific at risk body 
locations or things like specialized beds. They are designed to distribute the pressure on these at-
risk body locations so that pressure ulcers do not form. Offloading specialized beds can be fairly 
expensive and a hospital or hospice facility would need to purchase many of these to be effective 
for their entire facility [5]. As far as the specialized padding goes this is mostly for wheelchair 
applications and does not extend much to other at risk areas.  
 Motion Sensing  
This technique is mostly based on an electronic sensor containing an accelerometer. Leaf 
Healthcare has created such a product that senses motion and then predicts based on that motion 
data whether or not the patient is at risk of getting an ulcer [4]. This patch, shown in Figure 2.3. 
has shown to increase the compliance of the protocols already in place in hospitals (i.e. turning 
the patient) to prevent pressure ulcers [16]. The main draw-back for this type of device is that it 
does not actually measure pressure in the at risk areas of the body and so its predictive 
capabilities can only be so accurate.  
 
Figure 2.3: Leaf Healthcare Sensor 
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 Pressure Mapping and Pressure Mats 
This technique utilizes a specialized mat which can measure the contact pressure between 
the patient and its surface. The M.A.P.TM (Monitor Alert Project) system by Wellsense, Inc., 
shown in Figure 2.4, creates a continuous, real time heat-map-like display to show where the 
pressure is at a level that is likely to produce ulcers [3]. The main disadvantage of this system is 
that the pressure is measured based on the mat coordinate grid and not the patient themselves. 
This means that the patient could be moved and still be putting pressure on the same area of their 
body but the pressure mat wouldn't be able to distinguish this. 
 
Figure 2.4: M.A.P.TM System Mat and Visual Feedback 
None of these current techniques is perfect, each coming with its own disadvantages. 
There is still a large need for a low cost pressure prevention system. 
2.5 Relevant Products and Inventions 
While designing a new product for market, many design considerations can be made by 
examining pre-existing products. Many devices have been made for the prevention of pressure 
ulcers, however, few use sensors that adhere to the body. A summary of the data is displayed in 
Table 2.1. 
 Adhesive Sensor Technologies 
Leaf Patient Monitoring System 
Few adhesive patch sensors exist for the prevention of pressure ulcers, however, Leaf 
Healthcare has developed a sensor which can be adhered to a patient’s chest. This uses an 
accelerometer to determine if a nurse is has turned a patient who is at risk for pressure ulcer 
formation within the standard rotation period. If the sensor recognizes that the patient has not 
been turned within their rotation protocol, the system will alert the medical professional to turn 
the patient to prevent the onset of a pressure ulcer [19]. 
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Electrocardiogram Electrodes 
In order to visualize the electrical activity of the heart, an electrocardiogram must be 
tested on the patient. For this three or more electrodes, like the one shown in Figure 2.5, must be 
placed on the body [20]. While some applications may require the electrodes to be inserted 
below the patient’s skin, more frequently, electrodes are applied to the surface of the skin using 
adhesive patches. The patches must allow for the electrical signals to be detected by the electrode 
and they are often kept on the body for extended periods of time [21]. 
 
Figure 2.5: Electrocardiogram Electrode 
TempTraq®  
The TempTraq® patch by Blue Spark Technologies, shown in Figure 2.6, is a temperature 
sensor for constant body temperature monitoring for infants. The patch is adhered to the child 
and information is sent to a smartphone app recording a child’s body temperature history. This 
patch is wireless, disposable, and works for 24 hours [22]. 
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Figure 2.6: TempTraq® Patch 
 
 Skin and Wound Care 
Adhesive Bandages 
Adhesive bandages, like the one in Figure 2.7, are small dressings that are used to protect 
a small skin wound from external friction and contamination from debris and pathogens. An 
average adhesive bandage consists of an elastic layer with one side coated with adhesive, and on 
the adhesive side is a non-adhesive absorbent pad to adsorb excess bodily fluid from a wound to 
aid in healing. Adhesive bandages come in various shapes and sizes to fit different areas of the 
body. Also, different types are available for various needs which include but are not limited to 
durability, water resistance, antimicrobials, and breathability [23]. 
 
Figure 2.7: Adhesive Bandage on Knee 
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Dressings 
A dressing is a pad of material to protect a wound from further damage. It will absorb 
excess fluids, reduce pressure to the wound, and will prevent contamination by debris and 
foreign pathogens. Many dressings are held in place using bandages or medical tape, and some 
now are manufactured to be self-adherent to the body [24]. Typically, dressings are made with a 
silicone-based adhesive. Sometimes they are porous, and other times they may be 
hypoallergenic. The material is dependent on the function and application. 
Mölnlycke Health Care sells a sacrum foam dressing (Figure 2.8) to prevent and treat 
pressure ulcers. It is self-adherent, water-resistant, and has a foam pad which absorbs bodily 
fluids while also offloading pressure from the wound area to prevent further tissue damage [25]. 
 
Figure 2.8: Mölnlycke Health Care Sacral Dressing 
Medical Tape 
A wide variety of medical tapes, like the ones in Figure 2.9, are available for different 
needs. Fabric and cloth tapes are comfortable, breathable, and are often used for securing wound 
dressings and tubing [26]. They are also designed to be gentle on skin on removal. Paper tape is 
relatively cheap and is often used when re-taping is frequent [27]. Clear tape is used when 
securing tubing, stitches and other devices that require unhindered viewing [28]. Surgical tape is 
used to adhere to damp skin conditions [29]. For use during athletic activities, sports tape is soft 
and elastic and used to wrap around parts of the body providing light compression while 
protecting muscles from strain [30]. Elastic tape can be used wrap around a part of the body to 
apply compression [31]. Silicone tape is gentle on fragile skin and can be used for repeated 
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application [32]. All of these types of tape provide various characteristics that might serve well 
in the purposes of this project. 
 
 
Figure 2.9: Silicone (left), Surgical (center), and Cloth (right) Tapes 
Cosmetics 
Many products exist on the market to perform various cosmetic purposes. Silicone gel 
patches, like the one in Figure 2.10 are available to help heal scars by keeping the tissue 
moisturized which ultimately increases the compliance of the skin. These patches are flexible 
and form to the skin, and they are not painful when they are removed [33]. Furthermore, corn 
cushions, like in Figure 2.11, are designed to adhere around a corn or callus and a soft latex foam 
offloads pressure from the area to reduce pain and eventually reduce the size of a corn [34]. 
 
Figure 2.10: Silicone Scar Strip              Figure 2.11: Corn Cushions 
 Transdermal Patches 
Transdermal patches are designed to adhere to the body and release drugs into the skin 
over time. Depending on the application, patches can stay on the body from several hours to a 
week [35]. For example, Nicoderm® CQ nicotine patches by GlaxoSmithKline Consumer 
Healthcare, L.P. (Figure 2.12) are designed to stay on the body for 1 day to continuously release 
drugs that help a person quit smoking. The patch has a low profile and is often clear and 
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unobtrusive [36]. While the purpose of this project does not involve the administration of drugs, 
the adhesive materials can be examined and future applications of the project could involve 
adhesives that release medications that prevent the onset of pressure ulcers. 
 
Figure 2.12: Nicoderm® CQ Nicotine Patch 
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Table 2.1: Summary of Example Products 
Product Name Purpose Maximum 
Duration of 
Use 
Waterproof Device Material Adhesive 
Material 
Cost 
Leaf Healthcare 
Inc. Patient 
Monitoring 
System 
Contacts 
medical 
provider when 
patient has not 
been turned 
within rotation 
period 
Not accessible Yes Not accessible Not accessible $199 
Medtronic Inc. 
ECG Monitoring 
Electrode  
Detects heart 
activity 
Several weeks Yes Not accessible Gel adhesive $0.32 
TempTraqTM 
Thermometer 
Monitors body 
temperature; 
relays it to smart 
phones 
1 day Yes Polyethylene 
Foam 
Silicone gel-
based solution 
$19.99 
BAND-AID®  
Plastic Strips 
Protects small 
wounds from 
contamination 
Not accessible Can Be Not accessible Not accessible $0.03 
Mepilex® 
Border Sacrum 
Dressing 
Covers sacral 
wounds from 
further damage 
7 days Yes High MVTR Safetac® 
Silicone 
$17.20 
3M Co. 
MediporeTM  
Soft Surgical 
Tape 
Secure wound 
dressings 
Not accessible Resistant Fabric Gentle on skin $17.95 for 
2"X10yds 
Reliamed® 
Paper Tape 
Securing for 
frequent re-
taping 
Not accessible Not 
accessible 
Hypoallergenic 
Paper 
Gentle on skin $10.95 for 
2"X10yd 
CURITYTM 
Hypoallergenic 
Clear Tape 
Securing items 
with visible 
clarity 
Not accessible Not 
accessible 
Transparent, 
hypoallergenic 
Plastic 
Not accessible $12.95 for 
1" X 10yd 
3MTM 
MicroporeTM 
Surgical Tape 
Holds well to 
damp skin 
Not accessible Not 
accessible 
Paper Tape Hypoallergenic 
adhesive 
$11.95 for 
2" X 10yd 
Lightplast® Pro 
Elastic Athletic 
Tape 
Prevent strain 
during sports 
Not accessible Water 
repellent 
Cotton Zinc-Oxide 
adhesive 
$2.95 for 
2" X 5yd 
Tensoplast® 
Elastic Adhesive 
Bandage 
Apply 
compression to 
edema 
Not accessible Yes High tensile 
cotton cloth 
Not accessible $13.95 for 
2" X 5yds 
Mepitac™ Soft 
Silicone 
Waterproof Tape 
Secure medical 
devices 
Not accessible Yes Silicone and 
Polyurethane 
SafetacTM 
Silicone 
$17.08 for 
1.5" X 59" 
Dr. Scholl’s® 
Corn Cushions 
Removes 
pressure from 
affected area 
1 day Yes Latex pad Not accessible $2.32 
North Coast 
TopiGel® 
Silicone Gel 
Patch 
Covers scars to 
improve 
compliance 
6 weeks Not 
accessible 
Self-adhesive 
silicone 
Self-adhesive 
silicone 
$14.95 
Nicoderm CQ® Nicotine 
replacement 
therapy 
1 day Yes Not accessible Not accessible $2.78 
22 
 
3. CHAPTER 3: Project Strategy 
3.1 Initial Client Statement 
Develop a wearable disposable patch that would alert a patient or caregiver to a level of 
tissue pressure that would potentially be harmful to tissue or that could produce a pressure ulcer. 
The biocompatible patch should house embedded sensors that would monitor a limited number 
of at risk body areas to warn caregivers preemptively of impending tissue ischemia and injury.  
3.2 Technical Design Requirements 
There were several constraints and objectives that we derived from our initial client 
statement and used to assist us in the design process. These constraints and objectives are as 
follows. 
1. Water resistance: The material used for the patch must be able to protect the electronic 
components from water damage. 
2. Life Span: The adhesive patch should stay adhered to the patient’s skin for up to 7 days. 
3. Cost: The non-electronic components of the material should cost no more than $100 USD 
to manufacture. 
4. Sensor disposability: The patch should be designed such that the patch is completely 
disposable. 
5. Biocompatible: The patch must not cause any harm or damage to the patient and must 
follow all relevant biocompatibility guidelines set down by the FDA. 
6. Durability: The patch should be designed such that the electronic components will be 
protected from external mechanical forces. 
7. Size: The patch should be designed such that a relatively small skin surface area will be 
covered by each patch, and the patch will not exceed a thickness of 3mm.  
8. Budget: The total amount of money that can be spent on research and development of the 
patch not including the electronic components is $750 - $1000 USD.  
3.3 Design Requirement Standards 
The Food and Drug Administration (FDA) published a guidance document for “Tissue 
Adhesive for the Topical Approximation of Skin” [37]. Although this did not completely match 
the purposes of this MQP project, it did enumerate the many specifications for a product similar 
to an adhesive patch. The materials obtained for this project were already FDA approved for use 
on humans with limited potential for skin irritation.  
This MQP created a product to protect electrical components from damage. The final 
design of the product housed the electrical components, allowing the pressure sensor to read 
mechanical load, while also protecting the rest of the circuitry from breaking under such stress. 
Furthermore, the moisture sensor of the device needed to have access to the moisture of the skin, 
but the rest of the electronics had to be contained in a water resistant vessel to prevent short 
circuiting and potential harm to the patient. The final product was designed to satisfy these 
conditions.  
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Tests were conducted to determine the water resistance of the product, such as the 
method prescribed by ASTM D779-16 [38]. For this standard, ASTM suggested that a moisture 
indicator dye be used to measure the amount of moisture that passes through a given material. 
Additional ASTM standard test methods for tack, peel, and shear were performed to measure the 
adhesive properties of the adhesive materials used for the device. The procedures for these tests 
are outlined in ASTM D6195-03(2011), ASTM D3330/D3330M-04, and ASTM 
D3654/D3654M-06(2011) respectively [39-41]. The In-SpecTM 2200 machine was used to record 
the tensile forces that various adhesive materials can withstand before detaching from a 
substrate, as per ASTM D6195-03(2011) and ASTM D3330/D3330M-04. The time it takes an 
adhesive material to fail when loaded in shear was measured as outlined in the method ASTM 
D3654/D3654M-06(2011). Elastic modulus tests were also conducted using the Instron® 5544 
machine while following methods prescribed by ASTM E111-04(2010) [11].  
3.4 Revised Client Statement 
Develop a wearable disposable patch that alerts a patient or caregiver when unsafe 
conditions (such as elevated external pressure, tissue temperature and moisture) may produce a 
pressure ulcer. The biocompatible patch should house embedded sensors that would monitor a 
limited number of at risk body areas. The patch should be able to be worn for a maximum of 
seven days and allow for the electronics to be removed for reuse. The patch should be water 
resistant and materials should be sterilizable. The patch should cost no more than 20 US dollars 
not including the electronic components. 
3.5 Management Process 
After becoming more familiar with the project, the project was analyzed and broken 
down into tasks that were necessary to complete. The project was broken down into six main 
objectives and broken down further into secondary tasks. The outline of the main objectives of 
this project is shown in Figure 3.1. 
Once the project was organized into a work breakdown structure, it was necessary to 
create a timeline of the objectives (Figure 3.2) to ensure objectives were completed by the end of 
the academic year. 
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4. CHAPTER 4: Design Process 
This chapter will address how the team went about solving the challenges presented in the client 
statement of creating the housing for all the electrical components of a pressure ulcer prevention 
patch. 
4.1 Needs Analysis 
Based off the revised client statement, the team established the needs for the final product 
and the wants to have in the device. This was an important step as the wants and needs of the 
final product steer the design. In some of the initial designs, which will be discussed in Section 
4.5.1, the team failed to correctly identify some of the needs and so the designs were not 
ultimately viable. 
Biocompatibility was the most important need considered in the design process. If the 
device is not biocompatible, and if it causes harm to the patient, it cannot be used as a final 
product and will defeat its purpose. It follows that because of the importance of biocompatibility, 
the team limited the potential materials for the final product to only those materials that were 
already FDA approved, therefore being biocompatible and safe. 
The other need that greatly influenced the design was disposability. The final product 
must be completely disposable for it to be actually used by professionals in the healthcare 
industry. After discussions with plastic surgeons at University of Massachusetts Memorial 
Medical Center the team realized that healthcare professionals would not use a product that took 
more time to prepare than a Band-Aid or ECG electrode that can quickly be applied to the body 
and be thrown away afterwards. Asking healthcare professionals to take the time to recover non-
disposable components is not feasible. This steered the team in a direction to have both the 
sensor and patch as one assembled system rather than assembling the components when ready to 
use. 
As for wants, the team used weighting factors on a scale of 0-1 with 1 being the most 
important as shown in Table 4.1. These wants were identified through background research that 
had been done by the team and as requested by the plastic surgeons on the project. Their weights 
were given as deemed appropriate after having conducted extensive background research. The 
weights were confirmed as appropriate by the surgeons. Seeing as they work with pressure ulcers 
constantly, their feedback was invaluable. 
 Elastic modulus was the most important factor and was given a weighting factor of 0.29. 
The elastic modulus of the material determines its ability to conform to the body and stretch 
easily with movement. Skin has an elastic modulus of 1.0-4.0 MPa, but for this study it was 
decided that the average of 2.5MPa should be used [42]. If a material use has an elastic modulus 
greater than this, it may create and apply shear forces to the skin that counteract when being 
bent. This can in turn cause the material to be uncomfortable and may even cause damage to the 
skin. Elastic modulus was given a high weighting to select a material that could stay adhered on 
the body longer while also being comfortable. 
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Shear force was next most important and was given a weighting factor of 0.26. It was 
rated below elastic modulus because the team decided that shear force resistance of the adhesive 
is very important in order to achieve the goal of having the final product stay on the body for 
seven days but slightly less important than the elastic modulus. Shear force is the force applied in 
parallel to the adhesive surface and can be caused by any surface rubbing against the patch. This 
force causes bandages to come off the body before intended. By having a high shear force 
resistant adhesive, the amount of time a single patch can be used will be maximized.  
The next want was an adhesive with a low peel force. The peel force is the force it takes 
to remove an adhesive from the skin when grabbing one end of it and pulling in a perpendicular 
direction of the applied adhesive. Adhesives that have a peel force that is too high can lead to 
skin damage upon removal as the adhesive can actually pull portions of the epidermal layer of 
the skin off the body. Because patients who are most at risk for ulcers often have weaker and 
thinner skin than most, the final product should have a low peel force. This is because the final 
product should not cause injury to patients using it. The team weighted low peel force at a 0.21. 
This was rated slightly below shear since all the materials being tested are used for medical 
purposes on the skin already and should already cause very minimal damage.  
Water resistance was the next want that was identified. The team does not anticipate the 
patch to be completely submerged under water but should be able to repel water and other liquids 
to protect the electronic components from short circuiting and to prevent the adhesive from 
losing its strength. The patch should be able to stay functional even after being put into bathing 
conditions. The electronic components will be sealed in a plastic material that will provide 
protection from water damage. In addition, constant contact with water could affect the quality of 
the skin, leaving it more prone to damage, furthering the reason for having this factor weighed so 
heavily. For these reasons, water resistance was given a rating of 0.15.  
The final want identified was the ability to maneuver the patch if it is accidentally 
positioned incorrectly but not pressed down. Essentially, the patch should not be cumbersome. 
To determine this attribute in a quantitative way, adhesive tack force was measured which will 
be explained in more detail in Section 4.2.2. A low tack force indicates that the adhesive will be 
easier to use. This want was the least important and so rated at 0.09. 
This ranking system started by normalizing the results to 1 by dividing the best result for 
that test by the entire data set. This made it so the best result was equal to 1 and the worst result 
equal to 0. After that, the data set was multiplied by the tests’ respective weighting factor. For 
each material, the resulting number from each test was added up. The product with the sum 
closest to 1 was the preferable material. 
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Table 4.1: Design Matrix Factors 
Design 
Parameter 
Elastic 
Modulus is 
2.5MPa 
Shear 
Adhesion 
Force is 
High 
Peel 
Adhesion 
Force is 
Low 
Water 
Resistance 
is High 
Tack 
Adhesion 
Force is 
Low 
Total 
Normalized 
Weighting 
Factor (0-1) 
0.29 0.26 0.21 0.15 0.09 1 
Patch 
Component 
that Affects 
Parameter 
Backing 
Material & 
Adhesive 
Material 
Adhesive 
Material 
Adhesive 
Material 
Backing 
Material 
Backing 
Material & 
Adhesive 
Material 
 
4.2 Preliminary Material Selection Testing 
 Determining Materials to Test 
Many medical dressings and adhesive patches operate in a similar way to most single 
sided pressure sensitive tapes. They have a non-adhesive backing layer, and the adhesive is 
attached to that as shown in Figure 4.1. The adhesive material is the primary determinant of how 
well the tape sticks to a surface, however, the backing layer often determines key features such 
as the compliance/rigidity, water resistance, and external texture. 
 
Figure 4.1: Single-sided Pressure Sensitive Tape 
The medical field uses dozens of different adhesive materials and a similar number of 
backing materials. To fulfill testing on every adhesive-backing material combination would be 
costly and time consuming. Some materials, such as adhesives, require specialized 
manufacturing practices to create the product. Resources were not available for the team to 
accurately manufacture different adhesive medical tapes. Machine manufactured products are 
more consistent and accurate. If the team were to manufacture each combination of adhesive and 
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backing material by hand, there would be significant variability and heterogeneity in each 
sample, which would affect the results of the experiments.  
Although the team could not obtain every adhesive-backing material combination, a wide 
assortment of medical materials were obtained to analyze as many combinations to determine the 
best one for the device. Products were donated by Dr. Dunn and Dr. Hickle at University of 
Massachusetts Memorial Medical Center, requested as free samples from medical material 
providers like Mediplus Ltd., or purchased from local pharmacies like CVS. Table 4.2 
enumerates all the materials collected and various attributes.  
Since the products collected ranged in size and had various other components such as 
absorbent pads, a system was created to limit the variables that would influence the tests. For all 
the materials, the team collected information about the adhesive material, backing material, and 
adhesive area. Based on the design parameters enumerated by the design matrix in Table 4.1, the 
patch component that held the greatest weight on the design of the patch was the type of 
adhesive material. This component will greatly influence the various adhesive forces that 
determine the patch’s interaction with the skin. However, the backing material affects the patch’s 
ability to conform to the body, the tack force of the material, and water resistance. Therefore, 
within each adhesive material category, the medical products were organized based on their 
backing material.  
Additionally, in order to have enough material to create the amount of samples required 
for testing purposes, the adhesive area of products was evaluated. This was determined by 
measuring the length and width of the adhesive area. Furthermore, some products like the 
Curad® Bandages had a non-adhesive absorbent pad. These products were labeled with “border” 
indicating that they would have a significantly less adhesive material with which to work. 
Products that had an unobstructed adhesive area were labeled “entire”. The products labeled 
“entire” often had more material to use, and was often easier to use to make testing samples with, 
so these specific products were chosen for testing. However, if the team ran out of material from 
these products, samples were made using the “border” products given they had the same 
adhesive-backing material combination. The final products chosen for testing are indicated in 
Table 4.2 with an asterisk.  
The size of the material samples that were used for the tests was limited to the 
dimensions of the smallest medical tape (Steristrips®). Although they were 10 cm long, they 
were only 1.2 cm wide. The length of the sample adhesion area was then limited by the Curad® 
Bandages since the longest stretch of adhesive area of one tab was 2.3 cm before reaching the 
absorbent pad. Therefore, the adhesive area of the samples were limited to 2.3 cm x 1.2 cm. In 
order to properly load specimens for the tests, samples were cut larger than 2.3 cm. For example, 
the Curad® Bandage could be cut to be 3.0 cm x 1.2 cm. This would be done by including part of 
the absorbent pad in the sample. This did not affect the tests because only 2.3 cm x 1.2 cm areas 
would be adhered and the remaining length of sample would be used to clamp onto the sample. 
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Table 4.2: Material Information 
Product Name Adhesive Material Backing Material Dimensions Adhesive 
Area 
MediPlus™ Barrier Gel 
Comfort* 
hydrogel polyurethane 15.3cm x 
15cm 
border 
MediPlus™ HC Thin* hydrocolloid polyurethane 10.2cm x 
7.6cm 
entire  
MediPlus™ HC Foam 
Hydrocolloid Dressing 
hydrocolloid polyurethane 10cm x 10 
cm 
border 
MediPlus™ HC Comfort 
Hydrocolloid Dressing with 
Adhesive Border 
hydrocolloid polyurethane 15cm x 2cm border 
DuoDERM® Extra Thin 
Dressing* 
hydrocolloid hydrocolloid 10.3cm x 
10.3cm 
entire 
MediPlus™ PU Adhesive 
dressing* 
hypoallergenic 
polyurethane 
polyurethane 7cm x 6cm entire 
MediPlus™ Adhesive PU Pad hypoallergenic 
polyurethane 
polyurethane 5cm x 1cm border 
MediPlus™ Comfort Foam 
Dressing with Adhesive Barrier 
polyurethane  polyurethane 2.5cm x 
10cm 
border 
MediPlus™ Surgical Adhesive 
Nonwoven Dressing* 
low allergy adhesive 
polyurethane 
non-woven 
polyurethane cloth 
10cm x 5cm entire 
Tegaderm™ Film Dressing* acrylate/polyurethane rayon 10cm x 10xm entire 
NexcareTM Steri-StripTM Skin 
Closure* 
acrylate with "top secret" 
additives 
polyester/rayon 10cm x 
1.2cm 
entire 
Covidien™ Telfa™ Plus Barrier 
Dressing* 
acrylate woven cloth 15.2cm x 
2.5cm 
border 
Curad® Plastic Adhesive 
Bandage* 
acrylate plastic 2 cm x 7 cm border 
Transpore™ Surgical Tape* acrylate PEVA 2.5 cm x 90 
cm 
border 
Durapore™ Surgical Tape* acrylate silk/like polyester 2.5 cm x 90 
cm 
entire 
Curad® Cloth Tape* acrylate cloth 2.5 cm x 120 
cm 
entire 
Mepitac® Safetac® Medical 
Tape* 
Safetac® Non-woven film  4 cm x 90 cm entire 
Mepiform® Soft Silicone Gel 
Sheeting 
Safetac® Non-woven film  18cm x 10cm entire 
Allevyn® Sacrum Dressing Safetac® Non-woven film  21 cm x 21 
cm 
border 
Mepiplex® Border Dressing Safetac® Non-woven film  15cm x 2 cm border 
Scar Strips* silicone silicone 152cm x 
2.5cm 
entire 
MediPlus™ Silicone Comfort 
Border Dressing 
silicone silicone 1.2cm x 
7.4cm 
border 
*Product chosen for testing purposes  
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 Preliminary Non-human Material Testing 
Adhesive Shear Strength Test: ASTM D3654 / D3654M - 06(2011) - Standard Test 
Methods for Shear Adhesion of Pressure-Sensitive Tapes 
A 4 cm x 1.2 cm sample was cut from each medical product. The samples were marked 
with a permanent marker such that one end of each sample had a known area of 1.2 cm x 1.2 cm. 
This adherent area was placed on the edge of a steel plate (dimensions) with the excess material 
hanging off. A steel roller (0.90 kg) was used to roll even pressure onto this material. This was 
done by only guiding the roller over the tape, not by applying any additional force. This ensured 
that each sample was being adhered using the same amount of pressure. The steel plate was then 
attached to a lab bench so that the steel surface of the steel with the material was facing out from 
the lab bench and such that the steel was vertical with the sample hanging at the bottom of the 
plate. Using the overhanging extra material, a small loop of duct tape was secured and 400 g of 
mass was hooked onto the loop. As soon as the mass was released a stopwatch was started. The 
stopwatch was stopped once the mass caused the adhesive material to fall off the steel plate. This 
time was recorded. If the mass dropped and the adhesive material remained on the plate due to 
failure of the duct tape loop to remain adhered to the testing sample, then the test was restarted 
again using a new sample of the same material. The steel was washed with acetone between each 
test. The process was repeated twice for each material and the average time to failure was 
calculated. This preliminary data is located in Appendix A. 
The team’s testing methods differed slightly from ASTM D3654[8]. The standard asked 
for adhesion area of 6.5416 cm2 (1 in2). This needed to be smaller. Furthermore, due to the size 
change, the products could not withstand the 1000 g mass without failing immediately. The mass 
was therefore reduced to 400 g which was found to be the best weight during preliminary testing 
because the medical adhesives were able to withstand this weight for more than a second. 
Furthermore, the standard called for there to be enough material for the samples to form a tab by 
folding onto themselves. The weight would have hung from this. However, the size of the 
samples were too small to make these tabs, so the duct tape loop was constructed to provide a 
way for the mass to still put force onto the testing sample. This setup can be seen below in Figure 
4.2. The goal of this test was to find the highest shear. From this test, the top two materials were 
Nexcare™ Steri-Strip™ Skin Closure and Curad Plastic Adhesive Bandage™. 
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Figure 4.2: Shear Test Setup 
Adhesive Peel Strength Test: ASTM D3330/D3330M-04 - Standard Test Method for Peel 
Adhesion of Pressure-Sensitive Tape 
In order to test the peel adhesion strength of the medical products, the team followed the 
protocols prescribed by ASTM D3330 [7]. This test measured the amount of force that a medical 
product would be exerted on a steel plate when removed using a force perpendicular to the 
surface to which the product is well adhered. A 10.16 cm x 5.08 cm (4 in x 2 in) steel plate was 
bent into the shape in Figure 4.3. 
 
Figure 4.3: Steel L-Plate for Peel Test 
 A 4.0 cm x 1.2 cm sample was cut from each medical product. The samples were marked 
with a permanent marker such that one end of each sample had a known area of 2.3 cm x 1.2 cm. 
This adhesive area was placed on the long arm of the L-plate with the excess material hanging 
off the corner towards the short arm (Figure 4.3). A steel roller with a weight of 0.90 kg (2 lbs.) 
Adhesive Sample  
Steel Plate  
Mass  
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was used to roll even pressure onto this material. This was done by guiding the roller over the 
tape and not applying any additional force. This ensured that each sample was being adhered 
using the same amount of pressure. The short arm of the L-plate was then loaded into the clamp 
on the base of the Instron® 5544. The upper clamp was then lowered to a height 1 cm above the 
L-plate and the non-adhered end of the sample was loaded into the upper clamp. The Instron® 
was programed to extend upwards at a constant 5mm/sec and while collecting information about 
load (N) over the duration of the peel. The Instron® was manually stopped once the sample 
became completely detached from the L-plate. The process was repeated twice for each material, 
and the steel was washed with acetone between each test. The maximum load was identified for 
each trial and the average max load was calculated between repeat trials. This preliminary data is 
located in Appendix A. A diagram of the test is shown in Figure 4.4 below. 
 The test performed had a few major differences from the testing protocol in ASTM 
D3330. The standard called for testing specimens to be a width of 2.54 cm and the testing length 
to be at least 10.16 cm. However, due to the size of the materials, the size of the specimens 
needed to be changed. It was decided a 4.0 cm by 1.2 cm sample was appropriate and would 
keep the area constant throughout both the shear and peel tests. The goal of this test was to find 
the lowest peel force. The two materials with the lowest peel force was the MediPlus™ Barrier 
Gel Comfort hydrogel dressing and Durapore™ Surgical Tape. 
.   
Figure 4.4: Peel Test Setup 
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Adhesive Loop Tack Strength Test: ASTM D6195 - 03(2011) - Standard Test Methods for 
Loop Tack 
 
Figure 4.5: Example of Best Case Scenario for Loop Tack Testing [9] 
In order to test the adhesion tack strength of the medical products, the team followed the 
protocols prescribed by ASTM D6195 [9]. This test measured the amount of force that a medical 
product would exert on a steel plate when it has just touched the steel surface. It will determine 
the patch’s ability to be repositioned when it is accidentally adhered to the body without 
applying manual pressure. 
A 4.0 cm x 1.2 cm sample was cut from each medical product. The samples were marked 
with a permanent marker such that the center of each sample had a known area of 2.0 cm x 1.2 
cm. A mock piece of medical product with the same dimensions was loaded into the top clamp of 
the Instron® 5544 such that the 2.0 cm x 1.2 cm formed a loop below the clamp with the 
adhesive side facing out. The short leg of the steel L-Plate in Figure 4.2 was loaded into the 
lower clamp of the Instron® and the upper clamp was jogged down until the mock sample loop 
compressed into an inverted “T” shape on the steel plate. This setup is shown in Figure 4.5. At 
this position, the distance between the clamps was measured to be 0.5 cm, and the extension was 
zeroed on the Instron® console. The upper clamp was jogged back up and an actual testing 
sample was placed into the upper clamp the same way that the mock was before. The upper 
clamp was returned to the zero extension position, and immediately, the Instron® program was 
initiated, extending the upper arm upwards at a constant 5mm/sec while collecting information 
about load (N) over the duration of the test. The upper clamp stopped after moving 8 cm. Then 
the entire exposed area of the sample loop was coated with the red dye. A dye was created and 
composed of 30 mL clear Elmer’s glue and 10 mL McCormick Culinary red food coloring. This 
was created to measure the area of adhesion. Exactly 6 cm of white Curad® Cloth Tape was 
placed on the L-plate right below the sample loop. Next the upper clamp was returned to zero 
again and the Instron® cycle was initiated again. This left a print of the approximate area where 
the sample had touched down on the steel plate previously. The tape was labeled, the area was 
calculated using length and width of the print (since the prints were relatively rectangular), and 
the tape was put aside to dry. The process was repeated twice for each material, and the steel was 
washed with acetone between each test. The maximum load was identified for each trial and that 
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was divided by its respective area. The average max force per area was calculated between repeat 
trials. This preliminary data is located in Appendix A. 
The tack test varied greatly from the ASTM D6195 protocol. The materials used for the 
standard were assumed to be at least 2.54 cm wide, and the length would be sufficient to create 
loops using 10.16 cm of material. The loop created by this would press down onto a steel plate 
with an area of 6.4516 cm2 (1 in2) to get measurements in force per square inch. The product 
would press down on a known area since extra material that would bend with the loop would not 
have anything else to attach to. A L-plate was created for this standard that had the designated 
area; however, it could not be used for the purpose in the tests because the samples made were 
much smaller than the anticipated size from the standard. Had the tests been performed the same 
way, the area would have not been known to which the products adhered on the plate. For this 
reason, the team made the addition to the protocol to create dye imprints to measure the areas of 
contact. The team could not measure this area using a ruler while the sample was in the machine 
and touching down on the plate because the space was too confined to see measurements. The 
size limitations of the products greatly influenced how this test could be performed.  
The goal of this test was to find the lowest tack force per adhesion area. For this test, the 
top materials were the Curad® Cloth Tape, DuoDERM® Extra Thin Dressing and Covidien™ 
Telfa™ Plus Barrier Dressing, having the lowest tack adhesion force.  
Limitations with Adhesion Tests 
According to the ASTM standards, it was necessary to use stainless steel to conduct the 
shear, peel, and loop tack tests. Though the steel worked well, it is not representative of how 
wound dressings adhere to human skin. The wound dressings that were tested were pressure 
sensitive, meaning pressure affects how much the adhesive actually adheres to the surface. 
Pressure forces react differently on different materials, and human dermal tissue and steel are 
quite different. Further testing needed to be done before concluding what materials would be the 
best for this application. 
 Material Testing on Porcine Skin 
In order to obtain more realistic data, a more appropriate model was used to test these 
wound dressings. A porcine model was chosen. Porcine skin has been used in many applications 
before trials on human tissue because pigs have been shown to be one of the better animal-skin 
models due to the material properties[43]. Porcine feet were purchased at the local food store and 
the skin was removed with a scalpel. The standards that were used for testing did not prescribe 
methods for using porcine. However, ASTM F2256 Standard Test Method for Strength 
Properties of Tissue Adhesives in T-Peel by Tension Loading [7] did give this information, so 
the procedures for preparation were modified to meet the needs of the material testing protocols. 
Adhesive Shear Strength Test 
A few tests were performed using porcine skin with preparation guidelines from ASTM 
F2256. A 4 cm x 3 cm sample was cut from pig heels obtained from the local butcher. The 
samples were then cleaned with distilled water and a paper towel to remove contaminants and 
the piece was secured to the L-plate using clamps. The remainder of the test was the same as 
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when it was performed on the steel. These tests did not yield very good results because the 
medical products were not adhering to the sample. Results were inconclusive since the maximum 
time collected from a sampling of 6 different products was a partial seconds and due to the lack 
of adhesion to the sample itself. These materials should have adhered to the porcine skin, since it 
is a common model for human skin.  
Adhesive Peel Strength Test 
A few tests were performed using porcine skin with preparation based from ASTM F2256. For 
these tests, the Instron® was draped with blue chux to prevent contamination of the machine. A 
4.0 cm x 3.0 cm sample was cut from pig heels. The samples were then cleaned with distilled 
water and a paper towel to remove contaminants and the piece was secured to the L-plate using 
clamps, following the same setup as in Figure 4.4. The remainder of the test was the same as 
when it was performed on the steel. These tests did not yield useable results because the medical 
products were not adhering to the porcine model and the forces that were being recorded were 
very low, extremely noisy and out of range of the precision of the device. 
Adhesive Loop Tack Strength Test 
Tack tests were not performed on the porcine model. Porcine was not used because the 
forces measured from testing with steel were already low. Other tests had very poor readings 
with the porcine model, so it was concluded the forces read for this loop tack test with the 
porcine model would be too low to even obtain a reading. Furthermore, the products were not 
adhering to the skin when performing the peel tests as evidenced by the low values. Therefore, it 
was predicted that testing on porcine would yield inconclusive data. The decision to not perform 
tests on the porcine model was also justified due to the low weighting score that was assigned to 
this feature, since the data would not greatly affect the results in the design matrix. 
 Preliminary Human Material Testing 
Due to the lack of adhesion to the porcine skin and the noisy data obtained, it became 
evident that the porcine model was not an ideal model for further testing. The team decided to 
further investigate using a human skin model. These tests were all done via self-testing with only 
the members of this MQP team, since an IRB application was unable to be approved in a timely 
manner. 
Adhesive Shear Strength Test 
 As mentioned previously, the porcine model was not the most appropriate model to use. 
The team further investigated using a human skin model to collect the final data that would 
determine the best medical adhesive to use for this pressure ulcer sensor. As a trial, Benjamin 
Parent consented to having the test performed on the underside of his forearm. More details on 
this will be described later. However, what is important to note is that the team realized the 
adhesives adhered to human skin much differently than steel. This test that had just been 
performed was successful, and yielded appropriate data. Therefore, the results from shear tests 
on a participant’s forearm were going to be used as the final results for choosing the final 
material. The results are discussed in Section 5.2.2. 
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Adhesive Peel Strength Test 
Because the shear test on human skin had gone so well, the team looked into using the 
human forearm as a replacement for the steel plate in the peel test. In an attempt to collect more 
usable data, Rachel Ooyama-Searls consented to allow peel tests on her arm. In order to prevent 
Rachel from having to put her arm in the Instron®, the team designed a way for her to be a meter 
away from the machine. A meter long aluminum extension bar was located and this was loaded 
into the upper clamp of the Instron®. The test sample was adhered to the end of the extension bar, 
and Rachel’s arm was positioned under the sample. Her arm rested on a table that was the same 
height as the lower clamp of the Instron®. This setup is shown in Figure 4.6. The upper clamp 
was lowered to a height 1 cm above Rachel’s arm, the sample adhesive are was adhered to her 
skin, and the sample was secured onto the skin using the steel roller. The rest of the test followed 
the same extension protocol as previously stated. The results of this test yielded the top two 
materials being the MediPlus™ Barrier Gel Comfort and Tegaderm™ Film Dressing.  
 
 
Figure 4.6: Setup for Human Peel Test using Instron® 5544  
Adhesive Loop Tack Strength Test 
Preliminary tack tests were not performed on human skin. It would be hazardous to place 
an arm or other body part into the Instron®, trusting that the program would return the clamp to 
the same height. There is still the risk of crushing the limb. Furthermore, performing the test 
away from the machine like in the peel test, would still expose the participant to potential 
harmful compressive forces. The decision to not perform human trials was also justified to the 
low weighting score that was assigned to tack, since the data would not greatly affect the results 
in the design matrix. The team wanted to look into using another machine that would be safer to 
test with the human tissue model. 
Limitations with Instron® 5544 
The Instron® 5544 had a 2kN load cell. Because this load cell was so high and the data 
obtained had such low readings, it was concluded the data may be invalid. This load cell was not 
sensitive enough to read such low data accurately. To fix this, the team used another Instron® 
with a more appropriate load cell. This Instron® E1000 was located in Gateway and had a 50 N 
Extension bar 
Stationary Clamp 
Dynamic Clamp 
Sample 
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load cell. Unfortunately, after testing a few materials on the steel plate and porcine model, it was 
evident the data collected was also noisy and inconclusive just like the Instron® 5544. A different 
machine was needed for testing, one with a better load cell and safe to test the human tissue 
model. 
Acquisition and Setup of Instron® In-SpecTM 2200 
More conclusive tests were conducted by using an Instron® In-SpecTM 2200 Benchtop 
Portable with a ten pound load cell. This Instron® had a much more appropriate load cell and was 
quite small, decreasing the chance of any harm to any of the human subjects. In order to use the 
In-SpecTM, grips needed to be constructed such that specimens could be connected to the load 
cell. Nuts were superglued together to so the screw that came out of the load cell could be 
connected to an eye bolt. The threads of the screw and the eye bolt were different so the 
assembly was secured with wire and electrical tape. In order to properly grasp the material 
samples, grips were made using binder clips and these were secured onto the eye bolt using wire 
and electrical tape as well. 
The In-SpecTM 2200 differed from the Instron® 5544 in that the machine was designed to 
send load information to a personal digital assistant (PDA) rather than a computer. Since the 
machine did not come with a PDA, a new solution needed to be created to transfer the 
information to a computer to collect the data. Before this MQP, the output cable that would have 
been connected to the PDA was separated into two components: one that output displacement 
data and one that output load data. These components were connected to oscilloscope cables. For 
this MQP, the oscilloscope cable that output load data was used.  
A digital multimeter was used to collect data. For this, the negative and positive terminals 
of the load oscilloscope cable were connected to the respective AI0+ and AI0+ ports of a 
National Instruments Elvis prototyping board. The data was collected using the Data Logger 
application of the NI ELVISmx Instrument Launcher program. The Data Logger application 
saved data in .lvm type files so this was converted to .xlsm type files by opening the .lvm file 
using WordPad and saving the file as a .txt file. This .txt file could then be converted into a .xlsm 
file by using the Get External Data Import Wizard in Microsoft Excel.  
When the Data Logger was run, the data were collected in terms of volts so it needed to 
be converted to force (Newtons). This was done by collecting data for the voltage output for 
different masses that ranged from 0g to 1600g. 1600g was chosen because the predicted 
maximum load force from preliminary tests of the materials was about 3N, and 1600g was the 
equivalent of 15.7N. After the voltages were collected, they were input into an Excel sheet with 
the corresponding forces from the masses and plotted. A calibration curve was collected from the 
linear fit of the points and the equation of the line. This was used to convert subsequent voltages 
into forces. The protocol the team followed for using the In-SpecTM 2200 can be found in 
Appendix B, and actual testing protocols with the In-SpecTM 2200 are discussed in Section 4.3. 
This section describes each method actually used to determine the best material for this sensor 
rather than overviews of preliminary tests. 
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 Water Resistance Test 
In addition to the 90 degree peel, loop tack, and shear tests, the wound dressings were 
tested for water resistance. The original standard used was ASTM D779-16 Standard Test 
Method for Determining the Water Vapor Resistance of Sheet Materials in Contact with Liquid 
Water by the Dry Indicator Method [44]. The materials were cut into 1.2 cm by 2.0 cm samples. 
Weigh boats had a small 1 cm by 1 cm section cut out on the bottom. The wound dressings were 
adhered over the cut out section, such that the backing of the wound dressings was exposed to 
water. On the exposed adhesive section, an indicator powder made of powdered cane sugar, 
soluble starch, and methyl violet dye. The weigh boat was placed into a larger weigh boat filled 
with water. Water had gotten through to the adhesive when the indicator powder turned from 
white to purple. The standard called for timing how long it took for the rate of change in the 
indicator powder to increase rapidly. Seeing as how this is not a precise result, the team modified 
this standard by taking pictures of the sample every five minutes for a total time of forty minutes. 
This was determined by previous mock tests, observing that some materials exhibited some color 
change after five minutes, but not enough so that was deemed significant. After the forty 
minutes, water was poured onto the indicator powder to show what a positive control would 
look. The pictures would have been tested against the positive control by using an image analysis 
program, determining at which time point was there was a rapid increase in color change. After 
using this standard with five materials, it was concluded that this standard was not the correct 
procedure for this project’s purposes. The results obtained were not conclusive and difficult to 
interpret. 
To obtain water resistance data, a contact angle test was conducted. This test helps 
determine the hydrophobicity of a material. When the sensor is on the patient, it is anticipated the 
sensor will not be submerged in water but rather will roll off the sensor. This test will yield 
results of how likely water will roll off the material or adhere to it. A sample of the material was 
placed adhesive side down onto the bottom of the small weigh boat. Methyl violet dye was 
mixed with water and approximately 50 microliters of the purple solution was dropped onto the 
backing material of the wound dressing using a micropipette. The purple dye helped make the 
angle of the drop with the material easier to measure, due to the contrast of the purple against the 
white background. A picture was taken of the drop formed on the sample. The contact angle was 
found by using the image processing software ImageJ. This preliminary data is located in 
Appendix A. 
Though this contact angle test was helpful, the sensor will be exposed to water for some 
time, more than just what was needed to take a picture of the 50 microliter drop. Therefore, the 
team later adjusted the original testing standard so that usable results could be yielded. The 
actual protocol used for verification purposes is discussed in Section 4.3.4. 
 Elastic Modulus Test 
The final material test conducted was a test of each material’s elastic modulus. It is 
preferable to use a material that has an elastic modulus close to or identical to that of skin. When 
the adhesive material has a substantially higher elastic modulus than the skin, it can end up 
applying shear forces, which may contribute to forming a pressure ulcer. Not only would this, 
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but the shear forces that would be applied make the patch extremely uncomfortable. The elastic 
modulus of skin ranges from 1.0-4.0 MPa but for the project’s purposes the team used mean 
value 2.5 MPa as the elastic modulus for skin [42].  
For this test, a strip of each material was cut. Sizes of the strips varied based on the 
amount of material the team had to work with. The initial length, width, and thickness of each 
sample was recorded. After recording these measurements, forces were recorded while each 
sample was pulled in tension using the Instron® 5544 at a rate of 60mm/sec until the sample 
failed. Though many values obtained were below the threshold of 20 N (which is technically the 
lowest value that is considered accurate for the Instron® 5544), the other Instron® machines 
available to the team would not be appropriate for this application. This problem was solved for 
other tests by using the In-SpecTM 2200; however, this machine would not be usable for 
calculating elastic modulus because the full extension of the machine was too small to cause a 
failure of the sample in tension.  
MATLAB® code was written in order to calculate elastic modulus using the raw data .csv 
files the Instron® BlueHill® software exported. This code can be found in Appendix C. This code 
imported the force and extension raw data for each test. It then calculated the cross sectional area 
of each sample using the material width and thickness measurements imported from a separate 
measurements table .csv file. Next, it converted the force raw data into stress using Equation 1. 
Stress = Force / Area     (1) 
After that, it converted the extension raw data into strain using the initial length measurement 
from the measurement table and Equation 2. 
    Strain = Extension / Initial Length    (2) 
From there, it calculated multiple elastic moduli over the course of the test using a moving slope 
function. The moving slope function calculated the slope of stress-strain curve, but only over an 
interval of 10 data points. This function is depicted by the equation below. 
   Elastic Modulus = (Stress2 - Stress1) / (Strain2 - Strain1)  (3) 
These elastic moduli were then filtered to stop before a negative slope value was detected, 
indicating failure of the material. Finally, the elastic modulus for the material was determined by 
taking the maximum elastic modulus of this set. This protocol was repeated twice for each 
material, allowing the team to average the results and compare them with the other materials. 
4.3 Methods for Final Material Verification 
In Section 4.2, preliminary protocols were executed to help gain a better understanding of 
the tests themselves. In addition, the preliminary protocols gave the team a better sense of the 
material’s behavior. This information helped the team formulate the most appropriate protocols 
to determine the best material for this sensor. The following methods yielded the actual data the 
team analyzed for choosing this material. 
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 Elastic Modulus Test 
As mentioned in the previous section, using a material with a similar elastic modulus of 
skin is preferable. This way, the team can ensure the patch material will not cause irritation or 
harm to the skin near the application site. Section 4.2 described the protocol used for mock tests, 
which is the protocol the team decided to use for final testing. Results of this test are described in 
Section 5.2.1. 
 Adhesive Shear Strength Test 
Benjamin Parent consented to allow shear adhesion tests on his arm. The materials were 
of medical grade, and there was no risk of harm from a machine. Testing samples were cut, and 
the adhesive area was applied to Benjamin’s skin. The remainder of the test was the same as with 
the steel model. This data was quite different from the data obtained using stainless steel, thus 
leading to the conclusion that wound dressings adhere to different surfaces in different manners 
and a better human skin model is required for further testing. Results are discussed in Section 
5.2.2. 
 Adhesive Peel Strength Test 
To test on human skin, Brittney Pachucki consented to have the Peel Test conducted on 
the underside of her right forearm. Essentially, the same procedure was followed as with 
previous tests. A 4.0 cm by 1.2 cm sample was cut from each medical product. The sample was 
marked with a permanent marker such that one end of each sample had a known area of 2.3 cm 
by 1.2 cm. The sample was attached to the top grip of the Instron® In-SpecTM 2200 and was 
slowly lowered down towards Brittney’s arm on a spot that had been cleaned with an alcohol 
wipe. This adhesive area was placed on her arm and pressed down with fingers to ensure good 
adherence. The top grip was slowly brought up until the medical bandage was completely 
removed from Brittney’s arm. The process was repeated twice for each material to find the 
average peel strength, and her arm was cleaned with an alcohol wipe between each test. Results 
are in Section 5.2.3. 
 Water Resistance Test 
This test used samples that were cut to the dimensions of 1.2 cm by 2.3 cm and adhered 
to clear plastic squares that were roughly 1.5 cm2 in area. Before being adhered to the plastic, a 
team member applied a spot of just the dried dye (no starch or sugar) to the center of the 
adhesive side of the sample. This setup can be seen in Figure 4.7 below with both a negative test 
result (on the left) meaning it was water proof and a positive result (on the right) meaning it was 
not waterproof. The team made two of these plastic square setups for each sample and placed 
them in a shallow bin of water. All the samples were recorded by a video camera for the first 5 
hours and then checked on the hour for the next three hours. After that time period, the samples 
were then checked every 12 hours for the next 36 hours. Results were recorded during which 
hour each sample turned purple, and are discussed in Section 5.2.4. 
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Figure 4.7: Example of Water Test Samples 
 Adhesive Loop Tack Strength Test 
To test on human dermal tissue, Rachel Ooyama-Searls consented to having the Loop 
Tack test conducted on the underside of her right arm. Essentially, the same procedure was 
followed as with previous tests. A 4.0 cm by 1.2 cm sample was cut from each medical product. 
The samples were marked with a permanent marker such that the center of each sample had a 
known area of 2.0 cm by 1.2 cm. The sample was folded up, as with previous tests, and loaded 
into the Instron® In-SpecTM 2200. The sample was lowered down onto Rachel’s arm with a 
predetermined height of 2 cm. Once the sample touched down, it was lifted back up. A piece of 
tape was placed onto Rachel’s arm and the bottom of the loop was covered in dye. The sample 
was then lowered down again at the same height and left a print of the adhesion area. Data was 
calculated the same as before. Results are located in Section 5.2.5. 
4.4 Pre-Patch Material Duration Study 
While Shear Strength Testing was a good preliminary indicator for determining how long 
the product will stay on the body, the study did not actually test which material could stay on the 
longest. Performing such a test using all fourteen materials on the body with multiple samples 
would have been difficult, since this test would take up a large surface area of the body or 
require a great number of participants. Instead, the team concluded duration testing should be 
conducted on the two best performing materials from the material studies, TegadermTM Film 
Dressing and TransporeTM Surgical Tape both by 3M Co.  
Originally, the team intended on conducting a human study to test these materials on a 
large selection of participants. In this application, the team had created testing protocols for three 
types of tests: a duration study to tests the patch materials, a duration study to test the patch 
models, and a peel discomfort study that inquired about the potential for the patch to cause pain 
upon removal. This application was not passed, however, since more additional applications 
needed to be passed through the University of Massachusetts Memorial Medical Center 
Institutional Review Board as well to get WPI Health Services nurses to help participants in the 
43 
 
case of a reaction to testing materials. Due to the time restrictions of the MQP, the IRB 
application with WPI was withdrawn, and the team consented to performing tests on themselves 
to collect some preliminary data about the materials.  
The first test that the team partook in was the material duration study. The protocols from 
the application were adapted so that the team could complete more trials for more robust results. 
This test was designed to test the durability of TransporeTM versus TegadermTM to determine 
which material to use for a subsequent duration study of the actual patch shape. This material 
duration test also determined if the use of an AllKare® Barrier Preparation Wipe and its 
efficacies of prolonging the adhesive durability of medical products. This test lasted for eleven 
days and was repeated again at the end of the first cycle to obtain more data. The first test was 
conducted on the upper shoulders while the second test was conducted on the upper thigh. 
Figure 4.8 depicts the placement of the materials for this test. Each skin area was cleaned 
with an alcohol wipe and then eight 1.5 cm2 square adhesive samples were adhered onto each 
person. Sixteen samples were adhered in total, 8 on each arm, 4 of TegadermTM and 4 of 
TransporeTM on each arm. Samples were adhered in two rows of 4. The top row used an 
AllKare® Barrier Preparation Wipe, but the bottom row did not. Each row used 2 samples from 
each material. Each person in the team completed a Google Form survey every 12±1 hours for 
eleven days to grade the status of each material sample. Twelve hours was chosen as the time 
interval because it would allow respondents to record data in the morning after sleeping when the 
samples could have detached due to friction and shear forces experienced in bed, as well as in the 
evening after a day’s worth of activity that could have caused the samples to detach. Eleven days 
was chosen as the duration period because the material needed to stay on for 7 days. If both 
materials were able to stay on for this 7 day time period, the team would not be able to make a 
conclusion. The additional four days may have been when the materials would fallen off, 
allowing for statistical significance to be concluded between the two materials.  
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Figure 4.8: Setup of Pre-Patch Material Duration Test 
The survey used for this test is in Appendix D. The grading system for this test was based 
off the FDA’s draft guidance document for Assessing Adhesion with Transdermal Delivery 
Systems and Topical Patches for ANDAs. The FDA used a grading scale that ranked materials 
based on the criteria in Table 4.3. Essentially, for the MQP, the criteria for the scores were 
inverted from the FDA scores because when taking the surveys, it was more intuitive to rank a 
sample using a higher score if it had more material adhered to the skin. Conversely, it was more 
intuitive to rank a sample with a 0 if there was 0% of the material adhered to the skin. The FDA 
used its scores to later statistically analyze results system, so when the MQP team needed to do 
this, the data was converted to match the FDA grading system. Results of this study are 
discussed in Section 5.3. 
  
 AllKare®
 
Wipe 
No Wipe (Control) 
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TM
 Tegaderm
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Shoulder 
45 
 
Table 4.3: FDA Patch Adherence Grading System 
Score 
(Multiplier 
for 
Analysis) 
FDA Criteria MQP Criteria 
0 ≥ 90% adhered (essentially no lift 
off the skin) 
0% adhered (patch detached; completely off 
the skin). 
1 ≥ 75% to < 90% adhered (some 
edges only lifting off the skin) 
> 0% to < 50% adhered (not detached, but 
more than half of the patch lifting off the 
skin without falling off) 
2 ≥ 50% to < 75% adhered (less 
than half of the patch lifting off 
the skin) 
≥ 50% to < 75% adhered (less than half of 
the patch lifting off the skin) 
3 > 0% to < 50% adhered (not 
detached, but more than half of 
the patch lifting off the skin 
without falling off) 
≥ 75% to < 90% adhered (some edges only 
lifting off the skin) 
4 0% adhered (patch detached; 
completely off the skin). 
≥ 90% adhered (essentially no lift off the 
skin) 
The second test the team partook in was the patch duration test. Further details of this test 
will be described later in this chapter. Due to time constraints and prioritizing tests, the third test, 
peel discomfort test, was not conducted on the team members. 
4.5 Design Development 
 Preliminary Designs 
In the initial brainstorming and designing process, the team considered reusability as a 
want which differs greatly from the direction the project was taken, as disposability was a need 
for the final product. Additionally during the initial designs, the team made certain assumptions 
about how the electrical components would look and act that were incorrect. As a result the 
initial designs varied drastically with the final design that was ultimately decided on. 
The first step taken in the design process was to brainstorm ideas using different 
methods. The first method used was to think about and list all the concepts the team did not want 
the patch to do or to have. This was a good exercise in making a creative atmosphere as well as 
to get the team thinking about what the final product may need to do, not only to make it achieve 
certain goals but also how to design it to not have certain complications. After going through this 
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exercise the team brainstormed using a silent technique called a “round robin”. In this exercise, 
each teammate started with a sticky note and had one minute to draw and annotate a design for 
the final patch. After a minute was up, the design was passed to the person on the left. After 
looking at what was passed, the process of drawing a new design was repeated. This process was 
repeated five times and then as a team, all fifteen designs were looked at and discussed. This 
brainstorming session was useful in that it produced several different designs in roughly five 
minutes. From those initial fifteen designs, the team combined some together and came up with 
two separate ideas. Rough prototypes of these designs were made out of common materials that 
were readily available as shown below in Figure 4.9.  
For Prototype 1, the patch component consisted of two layers of adhesive material. The 
bottom layer adhered to the skin and the second adhered on top of the first. The bottom layer had 
a small circle cut out and between these two layers was a circle of release liner that would be 
removed so the electronic component could be secured in that space between the two adhesive 
layers. This design did not allow for easy insertion of the electrical components since the 
adhesive layers could quickly adhere to each other after removal of the liner. This design did, 
however, secure the electrical components in place, protect them from water, and allowed for the 
reuse of the electrical component. 
For the Prototype 2, a double layer approach was again used. This time the bottom layer 
consisted of two flaps that would fold down onto the electrical component to secure it. A hole 
was left at the intersection of the flaps to allow the sensor to access the skin for moisture sensing. 
This model also had release linings on both sides of the flaps as well as the exposed adhesive 
portion of the top layer to allow for easier electrical component insertion as well as to reduce 
contamination of the adhesive surfaces. Problems related to this prototype included water ingress 
at the seam of the flaps. However, this prototype did allow for easy insertion and removal of the 
electrical components and it secured the electrical components in place.  
Moving forward from the first two prototypes, a CAD design was used for the third 
prototype developed as shown in Figure 4.10. This design worked similarly to the second 
prototype where two flaps fold down and secure the sensor into place. The flaps had a hole for 
the sensor component to have contact with the skin. This also had removable release liners on the 
flaps and top layer to reduce contamination of the adhesive parts while also improving the ease 
of inserting the electrical component. The difference between this and the previous prototype 
Figure 4.9: Prototype 1 (left) and Prototype 2 (right) 
Mock Sensor 
Patch Flaps 
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was that the top layer overlapped beyond the flaps and it was cut to be a butterfly-like shape. 
This design has the potential to create many different shaped top layers to fit the various parts of 
the body where pressure ulcers form.  
        
Figure 4.10: Exploded Views of the Butterfly-Shaped Prototype 
 Alternative Designs 
 After presenting these designs to the electrical engineering team and to the project’s 
main clients, plastic surgeons from University of Massachusetts Memorial Medical Center, it 
came to the team’s attention that these designs were not feasible. This is due to disposability, 
which is needed in a hospital setting, and restrictions based on the electronic design. In creating a 
new design that would be feasible, the team worked closely with the ECE team designing the 
patch electronics and came up with three new designs shown below. The designs were based on 
research conducted on bandages for joints and limited by the design and size of the flexible 
circuit board. Having shapes with tabs allows for the stress to be distributed in such a way that 
the product will stay on longer.  
These designs contain the sensors for the patch in one of the end of the configuration as 
noted by the circles in Figure 4.11, and that end will need to be adhered to the body where a 
pressure ulcer may occur such as a bony prominence. The other end of all three designs contain 
the rest of the electrical components that do not need to be directly on the potential pressure ulcer 
site. All three of these designs consist of 5 layers. The bottom layer is an acrylate/polyurethane 
(determined by verification and validation methods explained further on in chapters 5 and 6) 
adhesive layer that will make direct contact with the patient's skin. The middle layer or third 
layer consists of the flexible printed circuit board and all the electronic components. It is 
surrounded and encased by the second and fourth layer which are made out of a waterproof 
polyethylene foam designed to protect the electronics. The bottom layer of foam and adhesive 
will have small holes corresponding to the temperature and moisture sensors on the flexible 
Part Number Part 
Name 
Description 
1 Fabric 
Adhesive 
Top 
Layer 
Adhesive on 
bottom side 
adheres to 
body 
2 Release 
Liner 
Remove to 
adhere 
sensor to top 
layer 
3 Flap 
Release 
Liner 
Remove to 
secure 
adhesive 
flaps onto 
sensor 
4 Adhesive 
Flaps 
Fold down 
over sensor 
to secure in 
place 
5/6 Patch 
Release 
liners 
Remove to 
adhere patch 
to body 
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circuit board. The top layer is a waterproof polyester/rayon (determined by verification and 
validation methods explained further on in chapters 5 and 6) backing material which will seal the 
whole design. The geometry of each patch design was heavily influenced by the circuit board 
design and the surgeons supporting this project.  
 
Figure 4.11: The three major designs used in the questionnaire 
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4.6 Final Design Selection 
When choosing between the designs there were two considerations: which patch shape is 
most intuitive to potential consumers, and which shape works the best on skin. The first 
consideration is important to this project specifically because if the sensor components of the 
patch are placed in the wrong positions, the technology will be unable to accurately predict if a 
pressure ulcer will form.  
 Patch Intuitiveness User Questionnaire 
To assess the first consideration, an interactive survey (shown in Table 4.4) approved by 
the WPI IRB was given to sixteen consenting participants. This survey started by asking 
participants to open mock patches, to gauge how easy it was to detach the packaging of this 
sensor. Occasionally, the packaging can damage the medical tapes, causing the adhesive to stick 
to itself. This part of the study ensured packaging was adequate for users. Then, using paper 
cutouts of each design one at a time, the participant was asked to demonstrate how they would 
place them on their heels and elbows. The participants were given no formal instructions other 
than to put it on their elbows and heels and a brief description of how and where pressure ulcers 
develop. Their responses were recorded and then the intended patch orientations were revealed to 
the participants. They were then asked which patch they found most intuitive and if there were 
improvements they felt should be made to each design. These design critiques were taken into 
account moving forward as the original shapes altered slightly. Both the “I” and “cross” shape 
patches were changed to have longer and larger tabs based on feedback from the survey (Figure 
4.12  and Figure 4.13). Additional views of these designs can be found in Appendix E. From the 
survey responses, it was determined that the most intuitive design was the “cross” shaped patch 
followed closely by the “I” shaped patch. All participants were students between the ages of 18 
and 22 that do not suffer from pressure ulcer complications. In the future it would be ideal to 
conduct this same survey with patients that are at risk of developing pressure ulcers and their 
caretakers. Results are further discussed in Section 5.4.  
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Table 4.4: Intuitiveness Questionnaire 
Questionnaire for Patch Usage Study 
How would you open the patch packaging before use? 
How would you place this patch on your heel? 
How would you place this patch on your elbow? 
In what orientation would you place it on those locations? 
What aspect of the design helped you decide how you were going to position the paper? 
After telling the participant has demonstrated how they would put on the three example 
patches, we will tell them the intended placement and ask the following questions: 
What change in the design would help you more to place it correctly? 
How do you think the design could be improved? 
How do you think the packaging could make the instructions clearer? 
 
At the end of the study, we will ask this final question: 
Which patch do you prefer and find most intuitive to use? 
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 Patch Design Duration Validation Study 
Our first consideration of the patch shape was the intuitiveness of the shape. The second 
consideration was which shape remained the best on the body. For the second consideration, 
human testing was performed on the members of the MQP team to determine which patch 
adhered best to elbows and heels. The team had hoped for a larger sample size rather than just 
the three team members, but because the IRB application was not approved in time, the team 
could only test on themselves.  
This patch design duration validation study was performed in order to determine which 
patch shape performed better and to determine if it could remain functional on the body for the 
seven days as prescribed by the client statement. For the first round of the study each participant 
wore 2 adapted “I” shaped patches and 2 adapted “cross” shaped patches, one for a heel and one 
for an elbow each. These adapted shapes were the changed versions of the designs after the 
interactive survey (Figure 4.12-Figure 4.15). Each patch had two layers of the adhesive material 
(one top layer exposed to the air and one bottom layer adhered to the skin) and a mock flexible 
PCB made of 4 sheets of KODAK Inkjet Photo Transparency Film that was positioned between 
two layers of polyethylene foam. A coin was flipped to randomly assign an “I” or “Cross” patch 
to adhere to the left or right heel and then elbow. The adhesive material of these initial patches 
was made of TransporeTM Surgical Tape by 3M™ (Figure 4.14).  
 
Figure 4.14: Transpore™ Patches for the Patch Duration Study 
This study was intended to last for seven days. Every 12 hours each participant scored 
their patches on a scale of 0-4. This scoring system was the same as the one used for the Pre-
Patch Material Duration Study in Chapter 4.4. Each participant also noted every 12 hours if the 
sensor was still functional, meaning that it was in the correct placement and adhered properly 
where the sensor would be. It was important that the sensor in the patches be placed on the bony 
prominence such that the sensor would be able to measure the appropriate data needed to detect a 
pressure ulcer forming. Because of this, if one side of the patch were to come off, resulting in a 
score of a 2, it mattered which side that was as one side contains the sensor. These responses 
were recorded in a digital survey (Appendix F) which stored the results in a Google spreadsheet.  
Mock Flex 
PCB Encased 
in Foam 
54 
 
Using TransporeTM Surgical Tape for the adhesive material of the patches led to 
significant skin irritation for all three participants, leading to the early termination of this study. 
This study lasted only three of the original seven days planned. Because of the irritation 
experienced, the patch failed in the essential biocompatibility aspect of the patch. Therefore, the 
study was terminated, and the next best performing material, TegadermTM Film Dressing by 3M 
Co., was used to construct and test the patches.  
 
Figure 4.15: TegadermTM Patches for the Patch Duration Study 
The same procedures were followed and the patches were adhered. After the 7 day study 
it was found that the “I” patch performed better than the “cross” shaped patch in that it stayed on 
the longest and had the sensor component of the patch adhered to the correct spot the longest. 
Based on the two considerations, the final design that both adhered best to the skin and 
was considered intuitive was the “I” patch design with the larger tabs shown in Figure 4.12.  
  
Mock 
Flex  PCB 
Encased 
in Foam 
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5. CHAPTER 5: Design Verification 
5.1 Design Overview 
In order to design an effective pressure ulcer prevention patch system, the two main 
factors to study were material selection and patch shape. It was necessary to select a material that 
would not cause harm to the user, adhere to skin for seven days, and prevent water from entering 
the patch. The ideal patch shape would cover a low surface area, be intuitive to the user for 
proper pressure sensor placement, and adhere to the skin for seven days. 
5.2 Final Material Results 
Unfortunately, due to the amount of testing the team had done, some materials had been 
completely used before being tested on the human tissue model. However, these materials had 
not performed well in the preliminary testing. It was concluded not testing these materials would 
not have made a difference on choosing the final material to use for the patch. 
 Elastic Modulus Test 
Testing was performed to find a material with an elastic modulus similar to skin (3.0-4.0 
MPa). This would allow the patch to put less tensile stress on the skin during everyday 
movements and potentially allow the patch to stay on longer. Table 5.1 displays the results of 
this test. Tegaderm™ film dressing by 3M Co. exhibited an elastic modulus that most matched 
that of skin compared to the other product samples.  
The average elastic modulus was taken over the two tests for each material. Since the 
ideal elastic modulus was 2.5MPa, percent deviation was calculated by entering this average into 
a percent error equation to normalize the data as shown in Equation 4.  
          % Deviation from Ideal = (Material E - Ideal E) / Ideal E         (4) 
In order to rank the data using the normalization method, for each material, the minimum 
percent deviation value of the all the results was divided by the material’s percent deviation 
value. From this method, Tegaderm™ Film Dressing and MediPlus™ Barrier Gel Comfort were 
the materials with the best elastic moduli. The Tegaderm™ Film Dressing had an elastic 
modulus of 2.67 MPa which deviated from the ideal 2.5MPa only by 0.066% and was within the 
3.0-4.0 MPa range.  
  
56 
 
Table 5.1: Final Elastic Modulus Test Results 
Product Name Average E (MPa) % Deviation from 
Ideal 
Normalized % 
Deviation 
Tegaderm™ Film 
Dressing 
2.67 0.066 1.00 
MediPlus™ Barrier Gel 
Comfort 
6.13 1.45 0.046 
Scar Strips 9.43 2.77 0.024 
Curad® Plastic Adhesive 
Bandage 
13.46 4.39 0.015 
MediPlus™ HC Thin 24.30 8.72 0.0076 
Covidien™ Telfa™ Plus 
Barrier Dressing 
26.52 9.61 0.0069 
DuoDERM® Extra Thin 
Dressing 
28.77 10.51 0.0063 
Mepitac® Safetac® 
Medical Tape 
36.86 13.74 0.0048 
Nexcare™ Steri-Strip™ 
Skin Closure 
51.30 19.52 0.0034 
Transpore™ Surgical 
Tape 
60.88 23.35 0.0028 
Curad® Cloth Tape 119.57 46.82 0.0014 
Durapore™ Surgical 
Tape 
585.51 233.202 0.00028 
 Adhesive Shear Strength Test 
The Shear Strength Test was conducted to find a material that would stay on the body the 
longest amount of time. To solve the problems experienced with the porcine model, Benjamin 
Parent consented to allow shear adhesion tests on his arm. The materials were of medical grade, 
and there was no risk of harm from a machine as will be discussed in later testing protocols.  
To normalize the data, for each material, the maximum shear time (excluding the Curad® 
Plastic Adhesive Bandage outlier) of the all the results was divided by the material’s shear time. 
The results and their normalized values are shown in Table 5.2. From this method, Curad® 
Plastic Adhesive Bandage and Transpore™ Surgical Tape were the top two materials for this 
design parameter. 
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Table 5.2: Shear Strength Testing Times on Human Skin 
Product Name Average Max Shear Time 
on Human Skin (sec) 
Normalized Shear Time on 
Human Skin Results (sec) 
Curad® Plastic Adhesive Bandage 71.48 1.00 
Transpore™ Surgical Tape 35.48 1.00 
Durapore™ Surgical Tape 18.94 0.53 
Covidien™ Telfa™ Plus Barrier 
Dressing 
8.59 0.24 
Nexcare™ Steri-Strip™ Skin 
Closure 
7.45 0.21 
MediPlus™ HC Thin 2.66 0.07 
DuoDERM® Extra Thin Dressing 2.23 0.06 
Mepitac® Safetac® Medical Tape 1.62 0.05 
Curad® Cloth Tape 1.48 0.04 
Polyurethane adhesive 1.07 0.03 
Tegaderm™ Film Dressing 0.79 0.022 
Scar Strips 0.73 0.021 
MediPlus™ Barrier Gel Comfort 0.61 0.017 
 Adhesive Peel Strength Test 
In order to ensure that the patch does not damage underlying skin upon removal, Peel 
Strength Tests were conducted. The goal of this test was to find the material with the lowest peel 
strength. 
In order to rank the data using the normalization method, for each material, the minimum 
peel force of the all the results was divided by the material’s peel force. These results are shown 
in Table 5.3. From this method, MediPlus™ Barrier Gel Comfort and Covidien™ Telfa™ Plus 
Barrier Dressing were the top two materials for this design parameter. 
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Table 5.3: Peel Force on Human Skin 
Product Name Average Max Peel Force on 
Human Skin (N) 
Normalized Peel Force On 
Human Skin Results 
MediPlus™ Barrier Gel Comfort 1.34 1.00 
Covidien™ Telfa™ Plus Barrier 
Dressing 
1.52 0.88 
Tegaderm™ Film Dressing 1.65 0.82 
Nexcare™ Steri-Strip™ Skin 
Closure 
1.82 0.74 
Mepitac® Safetac® Medical Tape 1.92 0.72 
Scar Strips 2.06 0.70 
Curad® Cloth Tape 2.17 0.65 
Polyurethane Adhesive 2.19 0.62 
Transpore™ Surgical Tape 2.21 0.61 
Durapore™ Surgical Tape 2.35 0.61 
DuoDERM® Extra Thin Dressing 2.78 0.57 
MediPlus™ HC Thin 2.89 0.48 
Curad Band Aid 3.16 0.43 
 Water Resistance Test 
Water was potentially hazardous to the patch for many reasons. It could short the 
electronics, get under the patch creating moist skin conditions conducive for pressure ulcer 
formation, or it could weaken the adhesive strength of the patch leading to premature 
detachment. Water resistance testing was performed to prevent this using an adaptation of ASTM 
STM D779-16 Standard Test Method for Determining the Water Vapor Resistance of Sheet 
Materials in Contact with Liquid Water by the Dry Indicator Method. The data for this test can 
be seen in Table 5.4. For this test the top tier was assigned to all the materials that did not fail 
after 5 hours of being submerged in water. This benchmark was established based on the 
assumption that patients wearing these patches would not be submerged in liquid for more than 5 
hours without a medical professional noticing, and the patches need to be able to repel water for 
the amount of time it may take a patient to shower or bathe which was reasoned to be a 
maximum of an hour.  
In order to rank the data using the normalization method, for each material, the material’s 
time was divided by 5hrs. The top materials based on this water test were materials 
DuoDERM™ Extra Thin Dressing, Tegaderm™ Film Dressing, Scar Strips, Covidien™ Telfa™ 
Plus Barrier Dressing, Mepitac® Safetac® Medical Tape, and Transpore™ Surgical Tape. 
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Table 5.4: Final Water Resistance Test Results 
Product Name Water Time (hr.) Normalized Water Results 
Scar Strips 5+ 1 
DuoDERM® Extra Thin Dressing 5+ 1 
Covidien™ Telfa™ Plus Barrier 
Dressing 
5+ 1 
Tegaderm™ Film Dressing 5+ 1 
Transpore™ Surgical Tape 5+ 1 
Mepitac® Safetac® Medical Tape 5+ 1 
Curad® Plastic Adhesive Bandage 4 0.8 
Nexcare™ Steri-Strip™ Skin 
Closure 
2 0.4 
Durapore™ Surgical Tape <1 0.2 
MediPlus™ HC Thin <1 0.2 
MediPlus™ Barrier Gel Comfort <1 0.2 
Curad® Cloth Tape <1 0.2 
Polyurethane Adhesive <1 0.2 
 Adhesive Loop Tack Strength Test 
Medical products sometimes get placed incorrectly when first being applied to the body. 
Therefore it is helpful to have a product that is capable of being readjusted when not yet fully 
adhered to the skin and secured. In order to ensure that the patch does not damage underlying 
skin upon removal in this situation, Loop Tack Strength Tests were conducted. To test on human 
epidermal tissue, Rachel Ooyama-Searls consented to having the Loop Tack test conducted on 
the underside of her right arm.  
In order to rank the data using the normalization method, for each material, the minimum 
tack force of the all the results was divided by the material’s tack force. These results are 
displayed in Table 5.5. From this method, Curad® Cloth tape and Durapore™ Surgical Tape 
were the top two materials for this design parameter. 
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Table 5.5: Tack Force on Human Skin using In-SpecTM 2200 
Product Name Average Tack Force/Area 
on Human Skin (N/cm2) 
Normalized Tack Force on 
Human Skin Results 
Curad® Cloth Tape 0.36 1.00 
Durapore™ Surgical Tape 0.36 0.99 
Nexcare™ Steri-Strip™ Skin 
Closure 
0.41 0.86 
DuoDERM® Extra Thin Dressing 0.43 0.83 
Covidien™ Telfa™ Plus Barrier 
Dressing 
0.44 0.82 
Transpore™ Surgical Tape 0.45 0.79 
MediPlus™ Barrier Gel Comfort 0.46 0.76 
Polyurethane Adhesive 0.47 0.75 
Mepitac® Safetac® Medical Tape 0.51 0.69 
MediPlus™ HC Thin 0.52 0.68 
Tegaderm™ Film Dressing 0.61 0.58 
Scar Strips 0.87 0.41 
Curad® Plastic Adhesive Bandage 1.25 0.28 
 Analysis of the Material Testing Data 
Table 5.6 is a compilation of the data from all five material studies. The average actual 
results for each material and for each test are displayed as the numbers without asterisks. 
Weighted results which are the normalized values of each testing set multiplied by the weighting 
score of their respective test are displayed as the values with asterisks. The Final Design Score 
for each material were calculated for each product by adding up all the weighted results in the 
product’s row. A perfect material that scored highest in all material studies would have received 
a Final Design Score of 1.0. The best product based on these Final Design Scores was 
Tegaderm™ Film Dressing by 3M Co. scoring a 0.67. Transpore™ Surgical Tape by 3M Co. 
was the second best material scoring a 0.61.  
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Table 5.6: Final Materials Selection 
Product Name 
Tegaderm™ 
Film 
Dressing 
Transpore™ 
Surgical 
Tape 
Curad® 
Plastic 
Adhesive 
Bandage 
Covidien™ 
Telfa™ 
Plus 
Barrier 
Dressing 
Durapore™ 
Surgical 
Tape 
Mepitac® 
Safetac® 
Medical 
Tape 
Nexcare™ 
Steri-
Strip™ 
Skin 
Closure 
DuoDERM® 
Extra Thin 
Dressing 
Scar Strips 
MediPlus™ 
Barrier Gel 
Comfort 
MediPlus™ 
HC Thin 
Curad® 
Cloth Tape 
Manufacturer 3M Co. 3M Co. 
Medline 
Industries, 
Inc. 
Medtronic 3M Co. 
Mölnlycke 
Health 
Care 
3M Co. 
ConvaTec, 
Inc. 
CVS 
Pharmacy, 
Inc. 
MediPurpose 
Co. 
MediPurpose 
Co. 
Medline 
Industries, 
Inc. 
Elastic 
Modulus Avg. 
(MPa)  
(WF = 0.29) 
2.67* 
(1.000)** 
60.88 
(0.003) 
13.46 
(0.015) 
26.52 
(0.007) 
585.51 
(0.000) 
36.86 
(0.005) 
51.30 
(0.003) 
28.77 
(0.006) 
9.42 
(0.024) 
6.13 
(0.046) 
24.30 
(0.008) 
119.57 
(0.001) 
Shear 
Strength Avg. 
Time (Sec.)  
(WF = 0.26) 
0.79 
(0.022) 
35.48 
(1.000) 
71.48*** 
(1.000) 
8.59 
(0.242) 
18.94 
(0.534) 
1.62 
(0.046) 
7.41 
(0.209) 
2.23 
(0.063) 
0.73 
(0.021) 
0.61 
(0.017) 
2.66 
(0.075) 
1.48 
(0.042) 
Peel Strength 
Avg.  (N) 
(WF = 0.21) 
1.65 
(0.817) 
2.21 
(0.608) 
3.16 
(0.426) 
1.52 
(0.883) 
2.35 
(0.571) 
1.92 
(0.699) 
1.82 
(0.740) 
2.78 
(0.483) 
2.06 
(0.652) 
1.34 
(1.000) 
1.87 
(0.719) 
2.17 
(0.619) 
Water 
Resistance 
Avg. Time 
(hr)  
(WF = 0.15) 
5+ 
(1.0) 
5+  
(1.0) 
4 
(0.8) 
5+  
(1.0) 
<1 
(0.2) 
5+  
(1.0) 
2 
(0.4) 
5+  
(1.0) 
5+  
(1.0) 
<1  
(0.2) 
<1  
(0.2) 
<1  
(0.2) 
Loop Tack 
Strength Avg. 
(N/cm2)  
(WF = 0.09) 
0.61 
(0.579) 
0.45 
(0.787) 
1.25 
(0.283) 
0.44 
(0.816) 
0.36 
(0.987) 
0.51 
(0.692) 
0.41 
(0.863) 
0.43 
(0.825) 
0.87 
(0.408) 
0.46 
(0.764) 
0.52 
(0.681) 
0.36 
(1.000) 
FINAL 
SCORE 
0.67 0.61 0.5 0.47 0.38 0.37 0.35 0.34 0.34 0.33 0.26 0.26 
* Plain vales are actual final results 
** Values in parenthesis are Normalized Results (NR) 
*** Outlier for this testing parameter 
Only 12 materials were used due to lack of enough materials
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5.3 Pre-Patch Material Duration Study Results 
 Tegaderm™  vs. Transpore™ Duration Study 
At the end of the two testing periods, the data was sorted by correspondent and adjusted 
to make logical sense. Occasionally a correspondent ranked a sample with a higher score than at 
a previous time point, having gotten confused as to which score was associated with which 
sample. Logically, the sample should not become better adhered after having poor adhesion, so 
instances where samples changed like this were edited to have the previous lower score. The data 
was analyzed in two ways: 1) Transpore™ versus Tegaderm™ and 2) AllKare® Barrier 
Preparation Wipe versus no wipe (control). 
First, the data from the Transpore™ versus Tegaderm™ results will be discussed. All the 
data was combined between the shoulder and thigh data. For each 12 hour time interval, the 
number of Tegaderm™ samples that scored a 4 was recorded. This was repeated for the 3, 2, 1, 
and 0 scores for all the 22 time intervals. This process was then repeated for the Transpore™ 
data.  
After finding these counts, weighted averages were collected for each material for each 
time interval. This was calculated by adding all of the products of the number of samples that 
ranked a giving score, x, multiplied by the score’s multiplier factor, w. Equation 4 enumerates 
this analysis and Table 5.7 shows all the material score counts and the respective weighted 
averages.  
   𝑊𝑒𝑖𝑔ℎ𝑡𝑒𝑑 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 =  ∑ 𝑤𝑖𝑥𝑖
4
𝑖     (4) 
The total weighted average of each material was also calculated. In summary, the 
material with a smaller weighted average performed better, where a perfect material would have 
scored a weighted average of 0. From these results, Transpore™ performed best in this duration 
test scoring a total weighted average of 1.75 (n=48) compared to Tegaderm™’s total weighted 
average of 2.45 (n=48). To test the statistical significance of these results, the materials’ 
weighted averages for the individual time intervals were input into a Two-Sample T-Test using 
Minitab statistical analysis software and a confidence interval of 0.05. From this, a p-value of 
0.048 was obtained indicating that the results of Transpore™ were significantly different from 
those of Tegadem™. 
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Table 5.7: Tegaderm™ versus Transpore™ Data, Weighted Averages, and Average Scores 
 Tegaderm™ Transpore™ 
Score 4 3 2 1 0     4 3 2 1 0     
Multiplying 
Factor 0 1 2 3 4       0 1 2 3 4       
Time Point 
(hr)           
Weighted 
Average 
Average 
Score 
ST. 
DEV           
Weighted 
Average 
Average 
Score 
ST. 
DEV. 
12 42 2 2 1 1 0.27 3.73 0.82 48 0 0 0 0 0.00 4.00 0.00 
24 29 12 4 1 2 0.65 3.35 1.02 41 7 0 0 0 0.15 3.85 0.00 
36 23 13 7 2 3 0.94 3.06 1.17 38 5 3 0 2 0.40 3.60 0.94 
48 22 12 8 2 4 1.04 2.96 1.25 29 12 5 0 2 0.63 3.38 0.98 
60 16 14 8 0 10 1.46 2.54 1.49 25 16 3 0 4 0.79 3.21 1.15 
72 11 19 8 0 10 1.56 2.44 1.41 22 19 3 0 4 0.85 3.15 1.13 
84 10 19 8 1 10 1.63 2.38 1.41 19 22 3 0 4 0.92 3.08 1.11 
96 8 16 5 1 18 2.10 1.90 1.60 17 24 3 0 4 0.96 3.04 1.09 
108 7 16 5 2 18 2.17 1.83 1.58 16 25 3 0 4 0.98 3.02 1.08 
120 1 16 7 2 22 2.58 1.42 1.41 8 31 3 0 6 1.27 2.73 1.14 
132 0 17 7 2 22 2.60 1.40 2.39 5 26 10 1 6 1.52 2.48 1.13 
144 0 13 9 2 24 2.77 1.23 1.32 4 23 11 1 9 1.75 2.25 1.25 
156 0 13 9 2 24 2.77 1.23 1.32 4 21 12 1 10 1.83 2.17 1.28 
168 0 10 6 3 29 3.06 0.94 1.26 0 19 14 2 13 2.19 1.81 1.23 
180 0 8 7 3 30 3.15 0.85 1.20 0 19 13 3 13 2.21 1.79 1.24 
192 0 7 6 3 32 3.25 0.75 1.16 0 15 9 7 17 2.54 1.46 1.27 
204 0 4 4 3 37 3.52 0.48 0.97 0 8 10 9 21 2.90 1.10 1.15 
216 0 4 4 2 38 3.54 0.46 0.97 0 8 7 8 25 3.04 0.96 1.17 
228 0 4 4 2 38 3.54 0.46 0.97 0 8 5 5 30 3.19 0.81 1.18 
240 0 3 2 4 39 3.65 0.35 0.84 0 5 3 4 36 3.48 0.52 1.01 
252 0 1 3 3 41 3.75 0.25 0.67 0 5 3 4 36 3.48 0.52 1.01 
264 0 0 2 5 41 3.81 0.19 0.49 0 5 2 3 38 3.54 0.46 0.99 
ALL 169 223 125 46 493 2.45 1.55 1.65 276 323 125 48 284 1.75 2.25 1.55 
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In order to visualize the difference between the two materials, Figure 5.1 shows the 
unweighted average score of each material for each time point. The average score was calculated 
using Equation 5, where S was the score, x was the number of samples that ranked the score, and 
n was the total number of samples for the given material in the given time interval. The vertical 
line indicates the 168hr (7 day) time point that the patch must remain adhered until. The 
horizontal line indicates where the material reaches 50% detachment. Since the linear fit line for 
Transpore™ had a smaller slope that indicates that, on average, its material samples remained 
better adhered to the body over the course of the study compared to Tegaderm™. 
    𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑆𝑐𝑜𝑟𝑒 =
∑ 𝑆𝑖𝑥𝑖
4
𝑖
𝑛
    (5)  
 
Figure 5.1: Tegaderm™ versus Transpore™ Average Score over Time 
 AllKare® Protective Barrier Wipe Duration Study 
The same analysis procedures were followed to analyze the material duration studies to 
determine a difference in using the AllKare® Protective Barrier Wipe. However, instead of 
separating the data based on material used, the separation was determined based on if the wipe 
was used or not. Table 5.8 shows all the material score counts and the respective weighted 
averages. From these results, both the AllKare® Protective Barrier Wipe and the control scored a 
total weighted average of 2.10 (n=48). To test the statistical significance of these results, the 
materials’ weighted averages for the individual time intervals were input into a Paired T-Test 
using Minitab® statistical analysis software and a confidence interval of 0.05. From this, a p-
value of 1.0 was obtained indicating that the results of the AllKare® Protective Barrier Wipe and 
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the control were statistically the same. This means that the AllKare® Protective Barrier Wipe 
does not improve the adhesive endurance of the material. 
In order to visualize the difference between the two materials Figure 5.2 shows the 
unweighted average score of each material for each time point. The vertical dashed line indicates 
the 168hr (7 day) time point that the patch must remain adhered until. Both testing conditions 
were able to remain adhered beyond this time point. Above the horizontal dashed line indicates 
the sample was more than or equal to 50% adhered. 
 
Figure 5.2: Effect of Barrier Prep Wipe on Material Adhesion over Time 
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Table 5.8: Barrier Wipe versus Control Data, Weighted Averages, and Average Scores 
 AllKare® Barrier Preparation Wipe Control (No Wipe) 
Score 4 3 2 1 0     4 3 2 1 0     
Multiplying 
Factor 0 1 2 3 4       0 1 2 3 4       
Time Point 
(hr)           
Weighted 
Average 
Average 
Score 
ST. 
DEV           
Weighted 
Average 
Average 
Score 
ST. 
DEV. 
12 48 0 0 0 0 0.00 4.00 0.00 42 2 2 1 1 0.27 3.73 0.82 
24 36 10 2 0 0 0.29 3.71 0.54 34 9 2 1 2 0.50 3.50 0.82 
36 30 10 5 0 3 0.67 3.33 1.10 31 8 5 2 2 0.67 3.33 1.10 
48 25 13 6 0 4 0.85 3.15 1.18 26 11 7 2 2 0.81 3.19 1.10 
60 20 15 6 0 7 1.15 2.85 1.37 21 15 5 0 7 1.10 2.90 1.37 
72 17 18 6 0 7 1.21 2.79 1.34 16 20 5 0 7 1.21 2.79 1.32 
84 16 19 6 0 7 1.23 2.77 1.32 13 22 5 1 7 1.31 2.69 1.31 
96 14 18 5 1 10 1.48 2.52 1.47 11 22 3 0 12 1.58 2.42 1.50 
108 14 17 5 2 10 1.52 2.48 1.49 9 24 3 0 12 1.63 2.38 1.47 
120 5 20 8 0 15 2.00 2.00 1.46 4 27 2 2 13 1.85 2.15 1.43 
132 3 18 11 1 15 2.15 1.85 1.38 2 25 6 2 13 1.98 2.02 1.36 
144 2 16 13 2 15 2.25 1.75 1.33 2 20 7 1 18 2.27 1.73 1.44 
156 2 14 14 2 16 2.33 1.67 1.33 2 20 7 1 18 2.27 1.73 1.44 
168 0 12 11 3 22 2.73 1.27 1.28 0 17 9 2 20 2.52 1.48 1.35 
180 0 12 9 4 23 2.79 1.21 1.29 0 15 11 2 20 2.56 1.44 1.32 
192 0 10 9 4 25 2.92 1.08 1.25 0 12 6 6 24 2.88 1.13 1.28 
204 0 6 8 5 29 3.19 0.81 1.12 0 6 6 7 29 3.23 0.77 1.10 
216 0 6 6 4 32 3.29 0.71 1.11 0 6 5 6 31 3.29 0.71 1.09 
228 0 6 5 3 34 3.35 0.65 1.10 0 6 4 4 34 3.38 0.63 1.08 
240 0 5 1 4 38 3.56 0.44 0.97 0 3 4 4 37 3.56 0.44 0.90 
252 0 4 2 3 39 3.60 0.40 0.92 0 2 4 4 38 3.63 0.38 0.82 
264 0 3 2 4 39 3.65 0.35 0.84 0 2 2 4 40 3.71 0.29 0.74 
ALL 232 252 140 42 390 2.10 1.90 1.62 213 294 110 52 387 2.10 1.90 1.61 
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5.4 Patch Intuitiveness User Questionnaire 
As described previously, the Patch Intuitiveness User Questionnaire was used to 
determine which patch shape of the major three was the most intuitive and user friendly. The 
results of the survey were coded for key concepts and tabulated (Table 5.9) and counts were 
taken of how many people placed the patch correctly (Table 5.10). This data was used to 
determine which two patch shapes would be used moving forward for the patch duration study 
and also to make shape adjustments before testing them. To determine which two patches to test 
moving forward, the team looked primarily at a combination of the counts of correct placement 
and also which patch participants said they preferred and thought was most intuitive. For the 
counts of correctness all the patch shapes scored relatively in the same range (Table 5.10). This 
range was between 25% and 31 % correct placement. Due to the closeness in results of counts, 
the team then turned to the participants’ responses about which patch they preferred and thought 
was best suited for our application. The results for this were more distinct with 10 participants 
choosing the “cross” patch, 5 participants choosing the “I” patch, and only 1 participant choosing 
the rectangle shaped patch. From these results both the “cross” and “I” patches were chosen to 
move forward with some adjustments. It was noted that 31% of participants suggested adding 
additional length to the tabs on the “I” and “cross” patches, which the team took into 
consideration. These adjustments were made (as seen in Figure 4.12 and Figure 4.13) for the 
patch duration study.  
Table 5.9: Coding Analysis of Questionnaire 
Codes Participant count (out of 
16) 
Participant percent 
Suggested Diagram or 
Instructions 
13 81.25% 
Preferred “I” Shape 5 62.50% 
Preferred Rectangle Shape 1 6.25% 
Preferred “Cross” shape 10 31.25% 
Suggested Moving Sensor 3 18.75% 
Suggested Extension of 
Tabs 
5 31.25% 
Suggested Changing the 
Peel-off Backing Shapes 
6 37.50% 
 
Table 5.10: Correct Placement Analysis 
Shapes Correct 
Placement on 
Heel 
Correct 
Placement on 
Elbow 
Total Correct 
Placements 
Percentage out 
of Possible 
Correct 
Placements 
“I” Shape 0 9 9 28.13% 
“Cross” Shape 0 8 8 25.00% 
Rectangle Shape 1 9 10 31.25% 
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6. CHAPTER 6: Design Validation 
6.1 Design Process 
Several studies were performed in order to develop the patch component of the pressure 
ulcer prevention patch system that adhered to the body. The MQP team began with researching 
the definition and causes of pressure ulcers as well as elements that make up other related 
adhesive medical devices. It was determined that the adhesive patch component consists of two 
key elements: the material and the shape. First, various materials were tested for key properties 
of elastic modulus, shear force resistance, peel force, water resistance, and tack force. These 
properties were analyzed using a feasibility matrix with weights supported by plastic surgeons 
who would be using the final product. TegadermTM Film Dressing by 3M Co. was determined to 
be the best material to use for the patch mainly due to its elastic modulus, and water resistance. 
This material needed to be verified, however, to determine if it would be able to remain adhered 
to the body for the seven day period required by the client statement. This material and the 
second best performing material TransporeTM Surgical Tape by 3M Co. underwent a 10 day 
verifying duration study to determine if they met this criteria. From this test, however, 
TransporeTM performed significantly better than TegadermTM. For this reason, the prior was 
chosen to test the various shapes of the patch design.  
From discussion with stakeholders, it was determined that another key property of the 
patch system was its ability to be placed correctly on the body. If the user places the patch 
incorrectly, the sensors will not read the correct data and may not alert a healthcare professional 
of an impending pressure ulcer. This would be detrimental to the patient and may also harm the 
healthcare professional due to malpractice litigation. For these reasons, the MQP team performed 
a Patch Intuitiveness Questionnaire with everyday people to determine which of the final designs 
of the patch were most intuitive for proper use and characteristics for improvement. With these 
results, the top two patch designs were improved and chosen for the validation study. 
 Validation Study Methodology 
The validation study was performed in order to determine if the model of the pressure 
ulcer prevention patch met the design criteria, while also testing the shape of the design. The 
patch would ideally be biocompatible, comfortable, water resistant, and stay on the body for 
seven days while still being functional.  
From all the material testing TransporeTM was chosen to perform this study, however, it 
failed in biocompatibility and water resistance. At day three, all three participants noted pain on 
both of their elbow patches. Two participants also experience skin tearing and deterioration. 
Since the purpose of the patch is to prevent pain from pressure ulcer formation, this model failed 
its biocompatibility test.  
TegadermTM scored the highest from the design matrix, but did not perform as well as 
TransporeTM in the Pre-Patch Material Duration Verification study. The latter is why it was not 
chosen as the initial material for the validation study. However, since TransporeTM failed 
TegadermTM was used as the backup material.  
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 Validation Study Results 
While performing the validation study conducted with TegadermTM, it was quickly 
apparent that the lifestyle of the participants greatly affected the condition of the patches. 
Patients at risk of developing pressure ulcers would likely not have similar lifestyles to those 
who tested the product. The MQP team is active, putting on and taking off shoes on a regular 
basis and showering every day. Because of this the heel patches became detached/nonfunctional 
within a few days of the start of the study. However, some elbow patches remained attached and 
functional until the end of the study showing that the design worked in this model. The data from 
the validation study surveys were analyzed using the same system used for analyzing the Pre-
Patch Material Duration Study discussed in Chapter 5.3, however, instead of comparing two 
materials used, it compared the “I” shaped patch to the “cross” shaped patch. The table 
displaying the combination of both elbow and heel data and results is located in Table 6.1. Using 
this analysis, the “I” shape patch received a total weighted average of 1.56 and the “cross” 
shaped patch received a 1.99, thus indicating that the “I” shape performed best. However, after 
performing a two sample T-Test of the two weighted average sets yielded a p-value of 0.121. 
Using a confidence interval of 0.05, this indicates that the choice of shape does not significantly 
affect the performance.  
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Table 6.1: "I" Shape versus "Cross" Shape Data, Weighted Averages, and Average Scores 
 "I" Shape “Cross” Shape 
Score 4 3 2 1 0     4 3 2 1 0     
Multiplying 
Factor 0 1 2 3 4       0 1 2 3 4       
Time Point 
(hr.)           
Weighted 
Average 
Average 
Score 
ST. 
DEV           
Weighted 
Average 
Average 
Score 
ST. 
DEV. 
12 3 2 1 0 0 0.67 3.33 0.82 2 4 0 0 0 0.67 3.33 0.52 
24 3 2 1 0 0 0.67 3.33 0.82 2 3 1 0 0 0.83 3.17 0.75 
36 3 2 1 0 0 0.67 3.33 0.82 2 3 0 0 1 1.17 2.83 1.47 
48 2 2 2 0 0 1.00 3.00 0.89 1 2 1 1 1 1.83 2.17 1.47 
60 2 1 3 0 0 1.17 2.83 0.98 1 2 1 0 2 2.00 2.00 1.67 
72 2 1 3 0 0 1.17 2.83 0.98 1 2 1 0 2 2.00 2.00 1.67 
84 2 1 2 0 1 1.50 2.50 1.52 1 2 1 0 2 2.00 2.00 1.67 
96 2 1 2 0 1 1.50 2.50 1.52 1 2 1 0 2 2.00 2.00 1.67 
108 2 0 2 1 1 1.83 2.17 1.60 1 1 1 0 3 2.50 1.50 1.76 
120 2 0 2 0 2 2.00 2.00 1.79 1 1 1 0 3 2.50 1.50 1.76 
132 2 0 1 0 3 2.33 1.67 1.97 1 1 1 0 3 2.50 1.50 1.76 
144 1 1 1 0 3 2.50 1.50 1.76 1 1 1 0 3 2.50 1.50 1.76 
156 1 1 1 0 3 2.50 1.50 1.76 1 0 2 0 3 2.67 1.33 1.63 
168 1 1 1 0 3 2.50 1.50 1.76 1 0 2 0 3 2.67 1.33 1.63 
ALL 28 15 23 1 17 1.57 2.43 1.57 17 24 14 1 28 1.99 2.01 1.58 
71 
 
In order to account for the poor data obtained from the heel study, the analysis was 
performed again using only the elbow data. In this analysis, the “I” shaped patch received a total 
weight average of 0.48 whereas the “cross” shaped patch received a 1.07. Inputting these data 
sets into the two sample T-Test yielded a p-value of 0.008 indicating that the “I” shaped patch 
was significantly better. As depicted in Figure 6.1, the “I” shape patch had an average score 
above 2 throughout the entire testing period, performing better than the “cross” shape. While 
these conclusions maybe be a good start, more testing on more people should be performed to 
obtain more robust results. 
 
Figure 6.1: "I" Shape versus "Cross" Adhesion over Time 
The data from this study were also analyzed for functionality. This is because a patch can 
be half off the body and receive a score a 2 but depending on which half of the patch is no longer 
adhered the body changes whether or not the patch is still functional. This happens as the result 
of the pressure sensor being on one side of the patch. On average the “I” shaped patches stayed 
functional for approximately 5 days whereas the “cross” shaped patches stayed functional for 
approximately 3.5 days. This data can be seen in Table 6.2.  
At the end of the TegadermTM study, it was noted that the patches seemed to dry out the 
underlying skin mainly in the center of the patch where there is less gas exchange with 
environmental air. Additionally, the patches could at times be itchy. This study was more 
successful than the TransporeTM study because patches were able to remain on the body for the 
full study period without inducing pain. It is possible that the size of the patch may have caused 
some of the biocompatibility issues, so efforts should be taken to reduce these dimensions. 
Additionally, for the elbows, minimal to no moisture was detected on the skin underneath the 
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patch indicating that the design was water resistant in practice. Using the “I” shaped patch with 
TegadermTM allowed the patch design to fulfill the needs of the design criteria. 
Table 6.2: Patch Duration Test Functionality Analysis 
 
6.2 Impact  
 Economics  
Our device could economically impact both hospitals and patients that are at risk/suffer 
from pressure ulcers and pressure ulcer related issues. Because Medicaid and Medicare do not 
fund hospital acquired pressure ulcer treatment, the brunt of this 11 billion dollars annually used 
to treat pressure ulcers falls on hospitals and patients [1]. Part of the reason these ulcers are so 
costly to treat is because they are very difficult to treat [13]. The lack of blood flow greatly 
increases the amount of time needed for healing. By preventing the ulcers from forming in the 
first place the bulk of the costs related to pressure ulcers would be eliminated. In comparison to 
the average cost of treating pressure ulcers these patches will be relatively low cost. There is also 
the alleviation of costs to hospitals in the form of reduction in lawsuits. Currently 3.7 billion 
dollars are spent annually on litigation over pressure ulcer related cases and are the second 
leading reason for lawsuits, with over 17,000 filed annually [1]. It is second only to wrongful 
death lawsuits. By reducing the number of pressure ulcers that develop, the number of lawsuits 
and the money going towards those lawsuits will also greatly decrease.  
 Environmental Impact 
In the original concepts for this design, our team had intended on making our device 
reusable discarding only the adhesive and foam components. The conceived design was to have a 
reusable flexible circuit board with a rechargeable battery. The circuit board and battery would 
have been able to be removed from a used patch and then reused in a new patch so that the 
amount of waste could be reduced. However, due to client concerns about ease of use and the 
need for the entire patch to be disposable, the design changed to be completely disposable. This 
means that there may be a negative impact on the environment from the device if it becomes the 
new standard in pressure ulcer prevention as it would most likely be disposed via landfill. 
However, our product also has the potential to positively impact the environment as it will 
reduce the waste associated with pressure ulcer wound care. Wound dressings are constantly 
changed in attempt to keep the ulcer clean to promote healing. All this medical waste would be 
significantly reduced because our product would prevent ulcers from forming in the first place. 
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 Societal Influence 
This device has the potential to not only improve the quality of life for the 1 million 
people in the United States with pressure ulcers but also to greatly reduce the amount of time 
spent by nurses and caretakers on preventing these pressure ulcers. By freeing up some of that 
time, nurses and caretakers are more able to spend their time caring for others rather than 
spending a significant amount of time caring for pressure ulcer sores. In addition, since the 
device has the potential to save hospitals in the US billions of dollars, collectively that money 
could be spent on new diagnostic equipment, funding for research, etc. that could help many 
more people now and in the future. Essentially this device has the potential to make a major 
impact not only for those afflicted by pressure ulcer but also for the medical community at large 
and anyone affected by a medical issue. 
 Political Ramifications 
This technology to prevent bedsores could potentially affect communities that hold strong 
religious beliefs against the use of technology. Traditionally the condition of pressure ulcers is 
prevented by routine monitoring by nurses without the use of electronics (though this method 
often fails to prevent pressure ulcers). If this device changes the standard practice for preventing 
pressure ulcers, hospitals may no longer continue with the traditional methods which would be 
more accessible to certain communities.  
This technology also has the potential to impact federal laws in the United States and 
how they deal with funding allotted to hospitals. Under the current system, the 25% of hospitals 
that have the highest incidence rate of pressure ulcers lose one percent in funding from the 
federal government each year. If this device is successful at reducing pressure ulcers and can be 
distributed equally to hospitals across the nation, then legislation that we currently have now 
could be removed.  
 Ethical Concerns 
The pressure ulcer prevention patch would in theory reduce the number of man hours 
spent by nurses caring for and manually preventing pressure ulcers. While this MQP views this 
as net positive by relieving overworked nurses, there does exist the possibility that some nursing 
positions may no longer be needed. This falls in line with any ethical concerns that arise as 
technology improves and can replace the manual work of humans. This team believes, however, 
that the net ethical benefits to patients’ quality of life outweighs the chance that there may be less 
need for nurses in certain areas. 
 Health and Safety Issues 
This device is designed specifically to prevent pressure ulcers, and in doing so, vastly 
improve patient quality of life. By preventing pressure ulcers this device has the potential to 
prevent approximately 60,000 deaths every year in the United States alone and the pain and 
suffering of over 1 million people [1]. As a medical device it is paramount that the device is 
biocompatible and safe for all potential users. To achieve this our team used only FDA approved 
materials currently on the market as medical adhesives and conducted extensive material tests 
including self-studies to make sure the patches were comfortable and did not harm the skin. The 
final material chosen for our device has an elastic modulus comparable to that of human skin 
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meaning that the material does not tug or pull on the skin while the patient is wearing it. The 
foam in the device is also designed to cushion those sensitive areas of the body and protect them 
from the electronics which or uneven heights on the flexible circuit board. The patch is also 
designed in such a way that there is no chance for electrocution as the electronics never come 
into direct contact with the skin and the board is also electronically insulated by the foam. 
 Manufacturability 
The potential for this device to be manufactured and produced is very high. All of the 
electronic components of this device and the material components can be purchased in bulk. 
Specifically, polyethylene foam is highly inexpensive and easy to manufacture and 3M Co. 
already manufactures high volumes of Tegaderm™ Film Dressing. Assembly would be similar 
to the TempTraq™ by Blue Spark Technologies which is a device that measures infant 
temperatures using a flex circuit board and foam encasement already on the market. If eventually 
this device is bought by 3M Co. then manufacturability only goes up as they have supply lines 
already in place. Ultimately, this device has great potential to be manufactured in bulk. 
 Sustainability 
There is no effect in terms of renewable energy for this project.  
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7. CHAPTER 7: Discussion  
7.1 Final Product 
The aim of this project was to create a device that would be able to secure a flexible 
printed circuit board to the skin for seven days while being biocompatible, comfortable, water 
resistant for up to five hours, and disposable.  
This validation study confirmed that the patch would remain functional for approximately 
five days. The “I” shaped patches outperformed the “cross” shaped patches in the duration 
validation study and the “I” shaped patches averaged about five days, just two days short of the 
seven day goal. While this is a shorter time span than ideal, the patch stayed on and was 
functional for multiple days which is the main intent of this wearable patch.  
Biocompatibility was achieved in the sense that only FDA approved materials currently 
on the market as medical tapes and adhesives were used in this project. As medical supplies 
already on the market, they are sterilizable and safe for use. For disposability, no toxic or highly 
expensive components were used in the making of the device. To confirm the water resistance of 
the final patch a water resistance validation test was done. The result from this test showed that 
the patch was water tight for over 5 hours  
The comfort of the patches was confirmed from the elastic modulus testing and validation 
testing. If the elastic modulus of a material significantly differs from skin, it will cause either the 
material to pull on the skin or the skin to pull on the material, which in turn causes discomfort. 
This idea was shown in the first failed validation test conducted by the team with Transpore™ 
Surgical Tape. The measured elastic modulus of this tape from the material tests conducted was 
60.88MPa which varies greatly from the 2.5MPa elastic modulus of skin. This test, which lasted 
only three days, caused notable reactions including skin irritation and pain on multiple 
participants. This round of validation tests was stopped immediately as the team noticed these 
adverse effects. The second round of validation tests used Tegaderm™ Film Dressing which has 
a measured elastic modulus much closer to that of skin at 2.1MPa. This test was able to be 
conducted for all seven days on some participants and there were no notable side effects. 
Participants also noted that the Tegaderm™ Film Dressing felt comfortable, often noting they 
had forgotten the patch was still on them.  
The team conducted a final very preliminary test with the flexible PCB board inside the 
patch. The goal of this test was to see if the sensors on the PCB could still read pressure 
temperature and moisture values. This test was done working with the electronics team that 
developed the PCB. The integrated patch sensor system can be seen in Figure 7.1. The wearer in 
this very preliminary test noted that the patch was able to comfortably bend with the body. More 
testing needs to be conducted in the future.  
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Figure 7.1: Preliminary Integration of Flex PCB in Adhesive Patch 
 Additionally the final patch is more user friendly when compared to other prevention 
devices on the market. Offloading boots are both cumbersome and only help prevent pressure 
ulcers on the feet. When compared to a thin wearable patch, the patch system is much more 
practical for a wider variety of patients on a wider variety of potential ulcer locations. When 
comparing the patch system to pressure mapping and motion sensing the potential for prevention 
is much higher with the patch system. This is because the patch system gets to the root of the 
issue which is detecting pressure ulcer conditions on different body areas. One might argue that 
pressure mapping also does this however, if a person shifts on the map the map cannot tell that 
pressure is still accumulating on the same body part. Finally, this patch system not including the 
electronics is extremely cost effective, potentially costing less than a dollar to create each patch. 
The electronics when manufactured in bulk would also be able to be quite cost effective.  
7.2 Caveats and Future Considerations 
One issue in this project was the small sample sizes for some of our preliminary material 
testing and verification testing. For the material tests supplies of each material were limited, 
leading to only two tests being done on each Instron® per material. For the validation tests, the 
low sample size came from not having IRB approval; therefore, the only the MQP team could 
test on themselves. Because of the small sample sizes the statistical significance may not be 
completely valid. The team suggests more robust testing in the future to gain a larger sample 
size. Another issue in this project is that all testing and questionnaires were conducted on 
healthy, active participants not at risk of developing pressure ulcers. To achieve a more accurate 
understanding of how the final device would stay adhered to the body of a patient at risk for 
pressure ulcers, studies need to be done with that population of people.  
In addition, the team suggests developing a diagram or instruction booklet for putting on 
the patches. This is based on the questionnaire results where 81% of participants suggested 
having instructions or a diagram in conjunction with the final patch for users. The team also 
suggests investigating further into the benefits of having rounded corners in the patch design 
(Figure 7.2) which would alleviate stress concentrations at the sharp corners of the current 
design. Finally, the last suggestion moving forward is that testing be done combining the real 
77 
 
flexible printed circuit board into the patch adhesive (instead of the plastic model used in these 
tests) and test duration and functionality of the device as a whole.  
 
Figure 7.2: Ideal Rounded Corner Integrated Patch Design 
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8. CHAPTER 8: Conclusions & Recommendations 
The intended product of this project was to create a housing component for a pressure 
ulcer prevention sensor. This housing component should be an adhesive patch that would adhere 
to an area of the body that would be at risk of forming a pressure ulcer. Ideally, this patch design 
should remain on the body for at least seven days, should be water resistant, and should be 
biocompatible. The final design was able to achieve most of these goals. 
Through various ASTM Standards and human testing, the team was able to determine the 
best material to use for this application, as well as the best shape the patch should be. Based on 
preliminary verification testing, the team was able to determine TransporeTM Surgical Tape by 
3M Co. was the most appropriate material to use. However, after validation testing, it became 
clear this material was not adequate for this purpose. Although this material performed the best 
in verification testing, in validation testing it proved to be uncomfortable, irritating skin and 
causing rashes and harm to the skin on all three human participants. The team deemed this as a 
design failure, and continued testing with the second best material, which proved to be quite the 
success. The material, TegadermTM Film Dressing by 3M Co., was comfortable, flexible, and 
biocompatible. It remained on the participants for an average of 5 days, was water resistant past 
5 hours, and caused no skin damage leading the team to choose this medical bandage as the final 
material to be used. To further ensure the electrical components would be protected, the team 
also decided to use polyethylene foam to encase the circuit board and protect against water. Also, 
the team recommends using rounded corners on the patch shape to alleviate any stress 
concentrations that may form due to corners of the patch shape. 
In addition to material testing, the team looked into the size and shape of the electrical 
sensor housing. This shape needed to be able to move with the joints of the body in a 
comfortable manner and not become detached. The team conducted a questionnaire to gauge the 
intuitiveness of different patch shapes. This data lead the team to further test the “I” shape and 
“cross” shape. After testing each shape on the three team members, it became evident that the 
best shape was the “I” shape. 
Further testing should be done to test other shapes of patches. Through this research, it 
became clear a different shape may be required for different joints and areas of the body. For 
example, the patches on the heels fell off much sooner than the patches on the elbows. Further 
testing should include looking into a more appropriate shape for the heel and shapes for other 
common risk areas. Different parts of the body are exposed to different forces and move in 
different manners than the elbow. Therefore, different shapes should be looked into in the future. 
In addition, it would be extremely valuable to test the patch on more than just three people. A 
sample size of three is not large enough to make a valid conclusion.  
The team's major recommendation is to construct the patch in an "I" shape using 
TegadermTM film dressing (with a backing material made of rayon and an adhesive layer made of 
urethane and acrylate polymers) to house and adhere the flexible PCB board to patients. 
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Appendix A: Data from Preliminary Material Selection Testing 
Product Name Shear 
Strength 
Avg. on Steel 
(Sec.) 
Peel Strength 
Avg. on Steel 
Using In-
SpecTM (N) 
Loop Tack Strength 
Avg. On Steel Using 
In-SpecTM (N/cm2) 
Contact 
Angle 
(Degrees) 
MediPlus™ Barrier 
Gel Comfort 
0.375 0.590265 0.3999114583 51.0 
MediPlus™ HC 
Thin 
13 2.012385 0.4982636218 69.4575 
Polyurethane 
adhesive 
21.03 1.491695 1.12235 75.717 
MediPlus™ Surgical 
Adhesive  
Nonwoven dressing 
101.805 1.400815 0.6614337662 127.4905 
Nexcare™ Steri-
Strip™ Skin Closure 
1173.51 1.23992 1.43662617 61.1285 
DuoDERM® Extra 
Thin Dressing 
24.635 1.400205 0.3411844729 102.0695 
Tegaderm™ Film 
Dressing 
0.765 0.728335 0.9138086111 75.9855 
Scar Strips 0.49 1.29827 0.8982091751 97.562 
Covidien™ Telfa™ 
Plus Barrier 
Dressing 
1.91 0.833015 0.3387135943 123.599 
Mepitac® Safetac® 
Medical Tape 
3.27 1.768895 1.281391204 93.127 
Curad® Plastic 
Adhesive Bandage 
975.84 1.020025 1.274719907 72.9315 
Transpore™ 
Surgical Tape 
340.685 0.74725 1.088230208 73.2405 
Durapore™ Surgical 
Tape 
194.66 0.649155 1.567225463 96.8055 
Curad® Cloth Tape 35.42 1.10244 0.211890625 100.4475 
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Appendix B: Protocol for In-SpecTM 2200 Use 
1. Prepare Hardware 
a. Plug in In-SpecTM 2200 and NI Elvis board into power socket 
b. Screw grip assembly onto the load cell 
c. Take red lead from alligator clip connected to center oscilloscope pin and insert 
into AI0 + on Elvis board 
d. Take black lead from alligator clip connected to center oscilloscope pin and insert 
into AI0 - on Elvis board 
e. Turn on both the In-SpecTM 2200 and NI Elvis board 
2. Prepare Computer Interface  
a. Open NI ELVISmx Instrument Launcher computer program if it does not 
automatically initiate 
i. Open Data Logger application 
1. Settings  
a. ai0 is chosen for data channel 
b. Sampling rate is 20 Samples/sec 
c. Choose file path for where to save the data by clicking on 
the folder to the right of the log button (make sure the file 
will save as an .lvm) 
3. Collect Data 
a. Click start button in Data Logger  
b. Click log button (this collects the data) in Data Logger  
c. Choose direction on the In-SpecTM 2200 (up or down) 
d. Press Start/Stop button on the In-SpecTM 2200 to make In-SpecTM move and begin 
testing 
e. Press Start/Stop Button on the In-SpecTM 2200 when done with test 
f. Press end in Data Logger  
4. Converting Data Type (.lvm to .xlsm) 
a. Open data file (.lvm) using Notepad 
i. Save as .txt file 
b. Open Microsoft Excel 
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i. Click Data tab>Get External Data>From text>choose .txt data file 
ii. Import Wizard 
1. Select “Delimited”> Next 
2. Delimiters are “Tab” and “Space”>Next 
3. General>Finish 
4. Choose New Spreadsheet>OK 
iii. The data is now in .xlsm (or other .csv type file) 
5. Convert output voltage to load (Max load of load cell is 50N) 
a. Collect data when 0g, 100g, 200g, 700g, 1200g, and 1600g are attached to the 
grips 
b. Plot the voltage output versus the corresponding weight (N) 
c. Use equation of linear fit line to convert output voltages of new data into loads 
 
C-1 
 
Appendix C: MATLAB® Code for Elastic Modulus Test Analysis 
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Appendix D: Google Survey for Pre-Patch Material Duration Study 
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Appendix E: Adapted Patch Designs CAD Models 
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Final “I” Shape Patch 
E-3 
 
E-4 
 
 
Final “Cross” Shape Patch 
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Appendix F: Google Survey for Patch Duration Validation Study 
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